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1 Introduction 
1.1 Biological membrane and membrane proteins 
(...) the chromocytes [erythrocytes] of different animals are covered by a layer of lipoids [lipids] just two 
molecules thick. (…) We therefore suspect that every chromocyte is surrounded by a layer of lipoids, of 
which the polar groups are directed to the inside and to the outside [of the cell], in much the same way as 
Bragg (1) supposes the molecules to be oriented in a 'crystal' of a fatty acid, and as the molecules of a soap 
bubble are according to Perrin (2). On the boundary of the two phases, one being the watery solution of 
hemoglobin, and the other the plasma, such an orientation seems a priori to be the most probable one. 
 
[Gorter, E. and F. Grendel, On Bimolecular Layers of Lipoids on the Chromocytes of the Blood. 31 Mar 
1925, [1]] 
 
In 1925, two Dutchmen, Gorter and Grendel extracted lipids from red blood cells, 
calculated the total area of a membrane they had purified, created the monolayer out of 
isolated membranes and finally measured the monolayer area. They observed that area of 
the monolayer was twice the estimated area of original membranes and thus concluded that 
the cell membrane is composed of two layers of lipids. Additionally, they correctly 
predicted the phospholipid molecules orientation in the bilayer. 
The biological membrane is key to the life of the cell. Membranes are the sheet-like 
structures made mainly of lipids and proteins. All cells are surrounded by plasma 
membrane that is 6 to 10 nm thick. Moreover, eukaryotic cells possess additional internal 
membranes around several organelles. Proteins are crucial for both membrane stability and 
function.  
In 1972, Singer and Nicolson proposed “the fluid mosaic model” describing the 
structure of biological membrane [2]. The model included aspects such as organization of 
lipid bilayers, diffusion of proteins and lipids freely within the plane of bilayer 
(membranes are two-dimensional fluids), embedding proteins into the lipid layers (mosaic 
formation) and an asymmetric distribution of proteins and lipids in the bilayer. However, 
years of membrane studies changed the general view in the membrane architecture [3]. It 
was verified that the membrane, which composition is not random, is rather mosaic than 
fluid. Besides, it was observed that membranes are patchy, with segregated regions of 
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structure and function. The next correction of Singer-Nicolson model concerned lipid 
regions that vary in composition and thickness. Within the bilayer, the clustering lipids 
form rafts that move around inside the cell and function as platforms for the attached or 
integrated proteins [4]. Additionally, the crowdedness of biological membranes seems to 
be much higher than assumed and the proteins inserted into the bilayer often have small-
spanning domains but huge ectodomains, which are limiting exposure of lipid to the 
aqueous regions (Figure 1.1). To summarize, the mobility of proteins in a lipid bilayer 
depends on lipid composition, thickness, protein crowding, and interactions with 
cytoskeleton and other proteins. 
Plasma membrane has many functions such as responding to external signals and 
transmitting them into the cell, providing a barrier to the water soluble molecules, transport 
of molecules via channels, cell-to-cell communication, separating cellular reactions by 
compartments and creating ion gradients between them, which are used for converting an 
energy and signal transduction.  
The biological membranes, depending on the cell or organelle specialization, vary 
in composition of the proteins that are scattered within lipid bilayer (Table 1.1), which are 
constantly in motion and perform most of the membrane functions.  
 
TYPE OF MEMBRANE 
COMPONENT 
SHORT DESCRIPTION EXAMPLE 
Transmembrane 
proteins (Integral 
proteins) 
Proteins have hydrophobic membrane-spanning 
domain in-between the lipids and hydrophilic 
cytosolic and extracellular domains that interact with 
internal and external molecules. The membrane-
spanning domain is made of α-helices and/or β-sheets 
motives. 
Aquaporins, G protein-
coupled receptors, ion 
channels, proton pumps 
Lipid anchored 
proteins 
Proteins covalently bound to the lipid molecules, 
which are inserted into the membrane; function as 
molecular switches. 
G proteins (guanine 
nucleotide-binding 
proteins) 
Peripheral proteins 
Proteins attached temporarily to the transmembrane 
proteins or associated with peripheral regions of 
membrane. After dissociation, function in cytoplasm. 
Some hormones and 
enzymes 
Phospholipids 
Class of lipids that is a major component of lipid 
bilayer. Typically contain a phosphate group, 
diglyceride, and a simple organic molecule (i.e. 
choline). Zwitterionic. 
Phosphatidylcholine 
(lecithin) (PC) 
Phosphatidylethanolamine 
(cephalin) (PE) 
Phosphatidic acid (PA) 
Phosphatidylserine (PS) 
Sphingomyelin 
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Glycolipids 
Membrane component composed of lipids that are 
covalently bonded to monosaccharide or 
polysaccharides. They function as energy sources and 
cellular markers. 
Glyceroglycolipids 
Glycosphingolipids 
- Cerebrosides 
- Gangliosides 
Cholesterol 
Sterol that stiffens the bilayer, decreases its 
permeability, regulates the activity of some integral 
proteins.  
In parallel, component of 
bile acids, steroid 
hormones 
(glucocorticoids, 
estrogens, androgens and 
progestagens) and fat-
soluble vitamins 
(A,D,E,K)  
Table 1.1: Main membrane components. 
 
 
Figure 1.1: Molecular model of the synaptic vesicle with inserted proteins. The 
macromolecules are presented at near atomic resolution. (a) Overview of the vesicle. (b) 
View of the vesicle cross-section. Lipids are colored in green and darker fragments of the 
bilayer correspond to the cholesterol molecules. Images were taken from [5]. 
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1.2 Aquaporins 
The New York Times (January 26, 2009) [6]: YOU WON THE 2003 NOBEL CHEMISTRY PRIZE FOR 
YOUR DISCOVERY OF AQUAPORINS. WHAT EXACTLY ARE THEY? 
 
Peter Agre: The plumbing system for cells. Every cell in our body is primarily water. But the water doesn’t 
just sit in the cell, it moves through it in a very organized way. The process occurs rapidly in tissues that 
have these aquaporins or water channels.  
Until 1985, when my lab found the protein they are made of, aquaporins hadn’t yet been identified. There 
had been a controversy in biology for more than 100 years about how water moved through cells. The 
assumption was that it somehow leaked through the cell membrane. And indeed some water moves that way. 
But the very rapid movement of water through some cells was not explained by this theory. 
 
The homeostasis of water, the most abundant molecule in living organisms, is crucial 
for physiology of all cells. Biological membranes have a defined lipid composition. To 
pass the lipid bilayer barrier water molecule needs activation energy of 10 - 20 kcal/mol. 
Nevertheless, in red blood cells, renal tubules or secretory glands incomprehensibly high-
rates of water transport were observed. The first proof of the existence of a water channel, 
which reduce the energy barrier in a cell to <5 kcal/mol, was given in 1984 by the 
observation that organic mercurials decrease water permeability in red blood cells. 
Additionally, the low channel permeability of H+ ions was explained by a specific fixed 
charge in the channel or the fact that water molecules within the channel do not form a 
continuum [7]. In 1992, it was discovered that oocytes from Xenopus laevis injected with 
in vitro-transcribed CHIP28 RNA exhibited increased osmotic properties due to water 
permeability. Experiments showed that the volume of the oocytes was increasing due to 
water uptake when incubated in hypoosmotic solution and proved that CHIP28, later 
renamed to Aquaporin-1 (AQP1), is the water channel protein in red blood cells [8]. 
AQP1, occurring at a level of ∼120000-160000 copies per cell, facilitates the water 
transport at a rate of 3 billion water molecules per second. Such transport is bidirectional 
accordingly to the predominant osmotic gradient. The Cys189 was identified as the Hg2+ 
inhibitory site [9]. 
Taking into account the myriad of physiological processes connected with water 
transport and diseases (nephrogenic diabetes insipidus [AQP2], congenital cataract 
[AQP0], onset obesity [AQP7]), the discovery of aquaporins was a breakthrough in 
physiology, biology and medicine. Peter Agre was awarded the 2003 Nobel Prize in 
Chemistry for his discovery of aquaporins. 
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1.2.1  Function and structure of Aquaporins 
Aquaporins were found in animal, plant, fungi and bacteria kingdoms of life. 
Ubiquitous process of aquaporin-mediated water transport across biological membranes is 
possible because of the special protein structure created by the fusion and duplication of 3 
transmembrane helices [10]. Aquaporins control flux of water out and into the cells. 
Several functions are attributed to aquaporins. Some aquaporin family members, called 
aquaglyceroporins, facilitate transport of glycerol, urea, carbon dioxide and arsenite in 
addition to water [11-13]. In prokaryotic organisms water channels are believed to protect 
against osmotic shock and sudden freezing, in eukaryotes aquaporins perform a number of 
physiological functions including concentrating the urine in kidneys, keeping water 
homeostasis in brain, excreting of moisture from sweat, tear and salivary glands, 
controlling glycerol uptake into the cell, supporting the buoyancy of fish-eggs in seawater 
and controlling opening and closing of flower petals [14].  
 
 
Figure 1.2: Image shows top view of the AQP0 2D crystal in the E. coli polar lipid bilayer 
at 2.3 Å resolution [15]. AQP0 tetramers are colored in green and the surrounding E. coli 
polar lipids in red. The AQP0 channels were marked with stars. The lipids in the central 
area between four adjacent tetramers marked with asterisks (*) were not defined. 
 
Aquaporins share the characteristic basic structure and features. In the biological 
membrane they form tetramers with each monomer functioning as a separate pore (Figure 
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1.2). The water is transported via pore using the osmotic gradient. Several studies focused 
on water transport through aquaporins, without passage of protons, were performed up to 
now. The high-resolution structure of AQP1 solved by electron crystallography in 1997 
[16, 17] revealed the “hourglass fold” predicted 5 years earlier by Jung et al. [18], which 
corresponds to the six transmembrane α-helices and seventh helix consisting of two half-
helices formed by loops B and E (Figure 1.3 A, B). Both loops B and E, which fold into 
the channel from opposite sites of the membrane, contain the highly conserved NPA (Asn-
Pro-Ala) sequence motif.  
Proton conduction in a bulk water proceeds due to the Grotthuss mechanism, which 
explains that protons are transferred between water molecules via hydrogen bonds and 
transient hydronium ions. Surprisingly, the study of water channel structure revealed the 
interrupted hydrogen bonds in the channel water chain and strictly defined orientations of 
water molecules in the pore. The mechanism of proton exclusion in aquaporins was 
reported and confirmed by molecular dynamics simulations that made it possible to 
observe the transport of water molecules through the pore.  
Since the α-helices have a natural dipole moment, the two half-helices in aquaporin 
oriented in opposite directions both position their positive dipole at the central NPA region 
of the pore. This creates the electrostatic barrier for the proton transfer, prevents water 
molecules from hydrogen bonding to adjacent water molecules, and induces alignment of 
the water molecules dipole moments (a rotation by 180°) as they pass the NPA aquaporin 
motif [19, 20].  
At the extracellular side of the pore the constriction region is located, which acts as 
the water filter. This region consisting of aromatic/arginine (ar/R) motif is a selectivity 
filter (Figure 1.3 C) conserved in all aquaporins. The diameter and polarity of this region is 
decisive for transport of molecules other than water.  
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Figure 1.3: Structural overview of aquaporins [14]. (A) Topographic representation of 
aquaporin shows the basic fold and highlights unusually long intra- and extracellular 
regions (red). (B) Water permeation through structure of human AQP5 [21]. Six trans-
membrane helices and two half-helices from loops B and E were highlighted in blue and 
yellow, respectively. (C) The aquaporin signature NPA-motif (asparagine, proline, alanine) 
and ar/R motif, which acts as selectivity filter, are shown in detail. 
 
Aquaporins are regulated posttranslationally by gating, whereby the flux rate 
through the pore is regulated, or by trafficking, whereby proteins are transported from the 
cell to the membranes. The phosphorylation at serine and threonine residues [22] plays the 
role both in gating and trafficking. Besides, changes in pH, osmolality and divalent cations 
concentrations can also influence the water transport in different cells [23]. Two 
mechanisms of aquaporin gating were proposed: capping and pinching (Figure 1.4, [24]). 
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The capping was reported to occur i.e. in SoPIP2;1 aquaporin present in spinach leaf 
plasma membranes, which gates when loop D and N-terminus cap the pore from the 
cytoplasmic side and moves residues to block the channel [25]. The pinching relies on 
movement of few residues that pinches upon ar/R region and restricts the passage of water 
molecules, and was suggested for i.e. mammalian AQP0 from eye lens fibre cells [26]. 
Additionally, two forms of AQP0 were observed: closed, forming highly ordered stacks of 
lens junctions upon proteolytic cleavage of the cytoplasmic termini, and opened non-
junctional forming the open water channel. Activity of AQP0, which have two histidine 
residues within pore, can be also regulated by changes of pH [23].  
In plants it was reported that there are at least two forms of the capping gating 
mechanism. As a response to drought the dephosphorylation of two serine residues 
(Ser 115 and Ser 274) of SoPIP2;1 regulates the gating, whereas during flooding, channel 
is closed in response to the drop of cytosolic pH and thus protonation of a fully conserved 
histidine (His 193) in the cytosolic D-loop [27].  
Human AQP2 is located in renal conducting duct. When the V2 receptor localized 
on the basolateral cell membrane binds hormone vasopressin, the AQP2 is phosphorylated 
by the cAMP dependent protein kinase A and transported to the apical plasma membrane 
[28]. 
 
 
Figure 1.4: Images of the capping and the pinching gating mechanisms in SoPIP2;1 
(green) and AQP0 (purple), respectively [24]. 
 
Thirteen aquaporin crystal structures solved by electron and X-ray diffraction at 
resolution better than 3.5 Å have been reported. These proteins are: ovine [26] and bovine 
[29] AQP0, human [30] and bovine [31] AQP1, human [32] and rat [33] AQP4, human 
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[21] AQP5, plant  SoPIP2;1 from spinach [25], bacterial [34] AQPZ, GlpF from 
Escherichia coli [35], Aqy1 from yeast Pichia pastoris [36], archeal AQPM from 
Methanothermobacter marburgensis [37], and PfAQP from parasite Plasmodium 
falciparum [38].  
To date, the thirteen mammalian aquaporins (AQP0-AQP12) were found, unique in 
their localization, regulation and trafficking. Channels AQP0, AQP1, AQP2, AQP4, 
AQP5, AQP6 and AQP8 belong to the group of aquaporins, while AQP3, AQP7, AQP9 
and AQP10 are included in the group of aquaglyceroporins, permeable to small polar 
solutes such as glycerol and urea in addition to water (Figure 1.5). AQP11 and AQP12 
belong to the unclassified aquaporin subfamily, not assigned to neither aquaporins nor 
aquaglyceroporins family. AQP6 and AQP8 are in aquaporin group only on the basis of the 
sequence analysis. The human aquaporins, AQP3, AQP7, AQP9 are permeable to urea, 
and AQP3, AQP7, AQP8, AQP9, and possibly AQP10, are permeable to ammonia. The 
new subgroup of NH3-transporting aquaporins called aquaammoniaporins was recently 
suggested [39, 40]. The characteristic of AQP0-AQP12 is shown in Table 1.2. 
 
AQUAPORIN 
MAJOR SITES OF 
EXPRESSION 
FUNCTION/COMMENTS REFERENCES 
AQP0 Eye: lens fiber cells  
Low water permeability 
Fluid balance within the lens 
Forms membrane junctions upon proteolytic 
cleavage, acts as adhesion protein  
At neutral pH its permeability is 40 times lower 
than that of AQP1 
Mutations cause congenital cataract  
pH, Ca2+/calmodulin regulated 
[26] 
AQP1 
Red blood cells, kidney: 
proximal tubule, eye: 
ciliary epithelium, brain, 
lung  
High water permeability 
Carbon dioxide permeability 
Osmotic protection  
Concentration of urine  
Production of aqueous humor and cerebrospinal 
fluid  
Alveolar hydration state 
Readsorbs 90 % of the 180 l of water filtered by 
the kidney per day  
Permeates water molecules across the membrane 
at a rate of 3 x 109 s-1 per channel 
[19, 41] 
AQP2 Kidney: collecting ducts, vas deferens  
High water permeability 
Stored in intracellular vesicles located 
throughout the cell 
Only aquaporin regulated by vasopressin 
Mediates antidiuretic hormone activity  
Mutations cause nephrogenic diabetes insipidus 
[11] [28] 
AQP3* Kidney: collecting ducts, trachea: epithelial cells, 
High water and glycerol permeability, 
moderate urea and ammonia permeability 
[42] 
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colon, skin, eye, lung Reabsorbtion of water into blood  
Secretion of water into trachea 
pH regulated 
AQP4 
Kidney: collecting ducts, 
brain, muscle, stomach, 
lung: bronchial epithelium  
High water permeability 
Reabsorbtion of water  
Fluid balance  
Osmosensing function 
Bronchial fluid secretion 
Functions both as water channel and cell 
adhesion protein, forms junctions 
[33] 
AQP5 
Stomach, duodenum, 
pancreas, airways, lungs, 
salivary glands, sweat 
glands, eyes, lacrimal 
glands, inner ear 
High water permeability 
Production of saliva  
Production of tears 
[21] 
AQP6 Kidney  
High water and anions permeability 
Localized intracellularly rather than at the 
plasma membrane 
Function as an ion channel  
pH regulated 
Water permeability is accompanied by an 
increased ion conductance with the following 
halide permeability sequence: NO3->I->Br->Cl-
>SO42- 
[43, 44] 
AQP7* Fat cells, kidney, testis, sperm 
High water, glycerol, urea, ammonia and 
arsenite permeability 
Responsible for glycerol release during 
starvation  
Has been proposed as a central agent in fat 
metabolism 
Mutations cause obesity  
[45] 
AQP8 
Pancreas, testis, liver, 
kidney, gastrointestinal 
tract, airways, heart, 
salivary glands 
High water, ammonia and hydrogen peroxide 
permeability 
Localized intracellularly rather than in the 
plasma membrane 
Neither urea nor glycerol can penetrate 
[43, 46, 47] 
AQP9* Liver, leukocytes, brain, testis 
High glycerol, ammonia, urea and arsenite 
permeability, and low water permeability 
Permits glycerol uptake for gluconeogenesis 
Permeable to olyols (e.g. glycerol and mannitol), 
purines and pyrimidines 
[48] 
AQP10* Intestinal epithelial cells, duodenum, jejunum 
High glycerol and urea permeability, and low 
water permeability 
Exists as two isoforms derived from two 
different transcripts, one is highly permeable to 
water, urea and glycerol, second shows only poor 
water permeability  
[49, 50] 
AQP11# Kidney, liver, testes, brain Does not transport water, urea, glycerol or ions [51] 
AQP12# Pancreas Localized in intracellular sites in acinar cells  Unknown function 
[52] 
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Table 1.2: Characterization of mammalian aquaporins. Aquaglyceroporins are highlighted 
with asterisks; pores not assigned to any of the groups are marked with a hash. Aquaporins 
with known structure are underlined.   
 
 
 
Figure 1.5: The aquaporin family tree [53]. Phylogenetic tree illustrates the relationship of 
the AQP0–AQP10 human aquaporins and the E. coli aquaporin homologues, AqpZ and 
GlpF. The aquaporins are typically permeated only by water and the aquaglyceroporins are 
permeated by water and small polar solutes. The scale bar represents the evolutionary 
distance: 0.1 equals 10 substitutions per 100 amino-acid residues. 
1.2.2  The human Aquaporin 8  
 The human AQP8 cDNA has been cloned in 1998 [54] after its identification one 
year earlier in mouse [55] and rat [54, 56]. Human AQP8 shares only 30-35% of sequence 
homology to other aquaporins and a sequence identity of 75 and 76% with, respectively, 
rat and mouse orthologs. AQP8 sequence is the most similar to the wheat AQP TaTIP2;1, 
which is able to transport ammonium (Figure 1.6). Both channels have unusually long N-
termini and shorter C-termini and their putative pores share most of the key residues 
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(His72, Ile198, Gly207, Cys208 and Arg213) [57]. By sequence alignment to AQP1 the 
supposed mercury-sensitive cysteine residue of AQP8 was determined: Cys208 in human, 
Cys209 in rat and Cys207 in mouse AQP8. On the phylogenetic tree of mammalian 
aquaporins AQP8 is at an equal distance from both groups of aquaporins and 
aquaglyceroporins (Figure 1.5). This divergence reveals uniqueness of AQP8 and suggests 
that it may belong to the new subgroup in mammalian aquaporins.  
 AQP8 is expressed in the inner mitochondrial membrane of several mammalian 
tissues as well as in liver and kidney where the urea and glycerol fluxes are essential for 
organism metabolism. In rat, the AQP8 was identified in the gastrointestinal tract, testis, 
airways and kidney cells, mainly in intracellular vesicles. In addition to AQP8, the only 
mammalian aquaporins reported to occur in intracellular vesicles are AQP2, AQP6 [43] 
and AQP12 [52]. This localization would suggest that AQP8 is not primarily involved in 
the water transport but rather in an osmoeqilibrium between vesicular and cytoplasmic 
compartments in a cell. Upon stimulation with the hormone glucagon AQP8 is 
redistributed to the canalicular membrane via a microtubule-depending, cAMP-stimulated 
mechanism [58]. 
In a liver, AQP8 appeared as glycosylated 34-kDa protein in intracellular vesicles 
and the apical plasma membrane domain [59], whereas in the mitochondrial inner 
membrane 28-kDa non-glycosylated form was found [47]. Interestingly, when AQP8 was 
expressed in yeast not only the 28-kDa AQP8 band appeared but an additional 26-kDa 
band was also identified suggesting that protein import into the yeast mitochondria is 
accompanied by a proteolysis of AQP8 N-terminus polypeptide [60]. 
In comparison to other aquaporins the less restrictive ar/R region of AQP8 allows 
polar solutes such as ammonia [40] and H2O2 [61] to permeate through the pore in addition 
to water, whereas neither urea nor glycerol can pass [54]. In the study of ammonia (NH3) 
and ammonium (NH4+) permeability in aquaporin-expressing Xenopus oocytes it was 
observed that AQP8 support significant fluxes of ammonia and has physiological 
implications for liver and kidney function [62]. In parallel, ammonia transport was 
determined in stopped flow light scattering experiments using formamide as ammonia 
analog. It was observed that formamide transport in mitochondria increased 3 times in the 
presence of AQP8 [60]. Additionally, it was reported that the mitochondrial AQP8 has 
preference for ammonia over water molecules. The ammonia permeability through the 
pore was determined to be 8 x 105 NH3 molecules/second/channel, twice higher compared 
to the permeability of water [63].  
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Ammonia transport facilitated by AQP8 might have significant physiological roles. 
AQP8 found in mitochondrial inner membrane and liver is speculated to be involved in 
cell-to-cell signaling, generation of reactive oxygen species [61] and urea cycle [62]. 
Moreover, it seems most likely that the diffusional transport of ammonia, which eliminates 
the severe neurotoxicity caused by hyperammonemia, could be a central function for 
AQP8 in mitochondria. 
In addition to above observations, many AQP8 studies gave contradictory results. 
The evidence against functionally significant expression of AQP8 in rat brain, liver and 
kidney mitochondria was published [64]. Therefore, it seems clear that there are still 
uncertainties regarding the physiological role and characterization of AQP8 within 
aquaporin family. 
 
 
 
Figure 1.6: Alignment of two aquaporins, 27.4-kDa human AQP8 to 25.2-kDa wheat 
Triticum aestivum TIP2;1. The sequence alignment was done using ClustalW2 [65] 
(default settings, matrix Blosum30, number of iterations 10) and graphically illustrated by 
ESPript 2.2 [66]. Identical residues are highlighted in red boxes and similar residues are 
framed in blue. 
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1.3 Type III secretion system 
I say, then, that the years of the beatific incarnation of the Son of God had reached the tale of one 
thousand three hundred and forty eight, when in the illustrious city of Florence, the fairest of all the cities of 
Italy, there made its appearance that deadly pestilence, which, whether disseminated by the influence of the 
celestial bodies, or sent upon us mortals by God in His just wrath by way of retribution for our iniquities, 
had had its origin some years before in the East, whence, after destroying an innumerable multitude of living 
beings, it had propagated itself without respite from place to place, and so calamitously, had spread into the 
West.  
 
[Giovanni Boccaccio (1313-1375), The Decameron – Introduction] 
 
The outer membrane of Gram-negative bacteria, besides the protection against 
harmful compounds like digestive enzymes, detergents and antibiotics in the extracellular 
environment, functions also as a barrier to uptake nutrients and secrete proteins. The 
transport of the hydrophilic molecules across the bacteria outer membrane is facilitated by 
a large variety of protein channels formed by substrate-specific porins and receptors. For 
the secretion of proteins Gram-negative bacteria have developed specific pathways that 
involve outer membrane proteins. In case of the type II and III secretion systems these 
outer membrane proteins are related and belong to the family of secretins, which includes 
also proteins involved in secretion of filamentous phages and assembly of type IV pili. 
The type III secretion system (T3SS) is special nanoscale machinery by which 
Gram-negative bacteria mediate protein translocation into eukaryotic cells. It has been 
identified in more than 25 different species of pathogenic organisms including Yersinia, 
Pseudomonas, Shigella, Salmonella, EPEC (enteropathogenic E. coli) and is essential for 
their virulence [67]. In parallel, it was reported that rhizobia, a diverse group of soil 
bacteria which induce the formation of nitrogen-fixing nodules on the roots of legumes, 
clearly exploit pathogenic secretion system and effectors for symbiotic purposes [68]. 
T3SS is composed of a cylindrical basal structure spanning the inner and outer 
bacterial membranes and the peptidoglycan, into which a hollow external needle is 
embedded and an array of effector proteins. The T3S apparatus, closely related to the 
flagellum, is a functionally and structurally conserved macromolecular machine consisting 
of ~25 different proteins. Bacteria docked to the surface of target eukaryotic cells or 
enclosed in the vacuole, deliver during infection the effector proteins across the membrane 
to the host cytoplasm or at the cytosolic face of the membrane [69-71]. Effectors injected 
to the cell have an influence on the biochemical and regulatory processes conducive to 
infection. They interrupt signaling cascades leading to phagocytosis, disturb the dynamics 
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of the cytoskeleton, control pro-inflammatory responses, induce apoptosis, prevent 
autophagy and influence the intracellular trafficking [72, 73].  
The Yersinia pestis bacterium has in the past caused the bubonic plague, called 
Black Death, which in years 1348-1350 spread throughout Central Asia, Mediterranean 
Region and Europe by fleas that made use of black rat (Rattus rattus). The pathogenicity of 
Yersinia resulted in unmatched devastation of people population in Europe (Figure 1.7). Y. 
pestis has imposing ability to overcome the mammalian host cell immune system and 
intensively multiply because of its pathogenic arsenal. Two another closely related food-
borne pathogens Yersinia enterocolitica and Yersinia pseudotuberculosis responsible for 
diarrhea and tuberculosis-like symptoms in humans, respectively, share with Y. pestis the 
core of the pathogenicity: the Yop virulon, which allows extracellular Yersinia to attach to 
the host cell surface and inject effector proteins across the membrane [74]. 
 
 
Figure 1.7: The figure shows images that correspond to the plague caused by the Gram-
negative bacterium Yersinia pestis. (a) Doktor Schnabel von Rom (Doctor Beak from 
Rome) engraved by Paul Fürst, Rome; 1656, [75]. A medical doctor equipped with wide-
brimmed black hat, long waxed coat, wooden cane and a bird-like mask with red glass 
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eyepieces and a long beak with pleasantly smelling herbs and spices visited patients 
afflicted with the bubonic plague. (b) Omne Bonum, a Fourteenth-Century Encyclopedia of 
Universal Knowledge, compiled by Cistercian James le Palmer, London; 1360-1375, 
British Library. A scene showing infected monks being blessed by a priest. (c) Plaque in 
Weymouth commemorates the arrival of plague in 1348. 
1.3.1 The needle complex 
The T3S apparatus is made up of 3 major parts: a cytoplasmic region (C ring), a 
region spanning both bacterial membranes and the peptidoglycan and the large external 
needle. The `needle complex` (or injectisome basal body plus needle), corresponding to the 
transmembrane and extracellular parts, was first isolated from Salmonella typhimurium 
[76] and visualized by electron microscopy in 1998. In 2001 the three-dimensional 
reconstruction of Shigella flexneri needle complex (Figure 1.8) with resolution of 17 Å 
from negatively stained particles was performed [77]. It was found that the complex is 
made of two sets of different diameter rings and the needle is a helical polymer of diameter 
of 7 nm and inner channel of 3 nm. Besides, four major components of the S. flexneri basal 
body’s transmembrane region were identified: two proteins in the inner membrane and a 
secretin in the outer membrane with attached periplasmic part of the needle [78, 79]. Cryo 
EM analysis and symmetry particle averaging of S. typhimurium needle complex [80, 81] 
extended the resolution, showed the inner rod with a central channel of 2-3 nm diameter 
connected with the hollow transmembrane chamber by the socket-like structure. The 
studies revealed that the secretion channel markedly narrows at the entry point to the 
needle. The rotational symmetry of the lower rings of the needle complex was determined 
to be 19-22-fold, in contrast to S. flexneri where side views of the needle complex 
correlated the best with 24-fold symmetry. The rotational symmetry of outer membrane 
secretins was reported to be 12-14-fold [82]. It was found that extracted needle complex 
structures have neither C ring, nor ATPase and transmembrane proteins that form the 
export apparatus, most probably because they are broken off during the purification 
processes. 
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Figure 1.8: Uranyl-acetate stained Shigella flexneri needle complexes taken from [83]. 
Well-preserved needles with the outer and inner membrane rings are indicated with white 
stars. Damaged particles are highlighted with black stars and top views of bases without 
needles with arrows. Scale bar corresponds to 50 nm.  
1.3.2 The YscC oligomer as part of Yersinia enterocolitica weaponry  
The injectisome acts as the syringe through which the Yop (Yersinia outer proteins) 
effectors travel unfolded from the bacterial cytoplasm across the both membranes and 
peptidoglycan, via needle to the host cell cytoplasm (Figure 1.9).  
In Yersinia spp., the T3SS is encoded on a virulence plasmid. However, the 
secretion of Yops can be artificially controlled and induced by incubation of the bacteria at 
37°C in media without Ca2+. Then, the secreted Yops have no cytotoxic effect on cultured 
cells, suggesting that physical contact of Yersinia with the host cell and translocation of 
Yops into the host cytosol is obligatory for Yersinia pathogenesis in vivo. Several Yersinia 
Yop effectors were identified, i.e. YopH (phosphotyrosine phosphatase which 
dephosphorylate adhesion proteins), YopP/YopJ (which have an anti-inflammatory role 
and induce apoptosis of macrophages) or YopE and YopT (which inactivates GTPases that 
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control cytoskeleton dynamics) [74]. To inject the Yop effectors the physical contact of the 
needle with a host cell is necessary. 
Approximately 25 types of proteins are needed to build the injectisome. They are 
structural components, molecules involved in the assembly process and function of the 
injectisome, i.e. molecular ruler and chaperones. In Yersinia, these proteins are called from 
YscA to YscY (Yop secretion). The highly conserved injectisome, made of Ysc proteins, 
consists of cylindrical basal body submerged in both bacterial membranes joined by a 
central rod and connected to the hollow needle (Figure 1.10). 
 
BACTERIA 
Yersinia 
enterocolitica Shigella flexneri 
Salmonella 
typhimurium 
EPEC 
(enteropathogenic  
E. coli) 
YscC (secretin) MxiD InvG EscC 
YscW (pilotin) MxiM InvH  
YscJ (inner ring) MxiJ PrgK EscJ 
YscD (connector) MxiC PrgH EscD 
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YscF (needle) MxiH PrgI EscF 
 
Table 1.3: Injectisome components homologues. 
 Needle (needle: YscF, tip: LcrV, translocation pore: YopB, YopD, length 
control/molecular ruler: YscP) 
The Y. enterocolitica injectisome needle is a hollow stiff tube 65±10 nm long and 7 
nm thick, with an inner diameter of about 2.5 nm. The needle, which is formed by 
polymerization of 139±19 subunits of the 9-kDa-protein YscF with fixed twist of 5.6 
subunits per turn, terminates with a bell shaped tip structure constructed by a 
homopentamer of the protein LcrV [84-87].  
The needle does not puncture the target cell but upon the contact with the host 
membrane builds a translocation pore using two hydrophobic proteins YopB and YopD. 
One of the translocon proteins (YopB) interacts with the tip protein using its N-terminal 
domain, which influences a proper YopB insertion into the host membrane. The 
translocon, embedded in a membrane, is made of 6-8 subunits of both proteins as was 
revealed by EM and AFM [69, 88]. It was shown that in the absence of any of the 
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translocon components, Yops are secreted out of the bacteria but are not able to enter the 
host cell.  
The structure of the needle-tip acts as an assembly platform for the translocation 
pore [89]. After assembly of the basal body, which is the core of an export machine, the 
needle subunits are exported. The same machinery changes the substrate specificity over 
the time and transfer sequentially translocation pore proteins and effectors. 
To reveal the needle structure several studies were performed using the 
homologues needle subunits, MxiH (S. flexneri), BsaL (Burkholderia pseudomallei) and 
PrgI (S. typhimurium). They shed light onto the atomic resolution structure of ‘building 
blocks’ of the needle. All the needle components structures have the two-helix bundle 
coiled-coiled motif, which was docked into 16 Å EM density reconstruction of S. flexneri 
needle and provided atomic predictions of the helical needle structure [90].  
The YscP protein acts as a molecular ruler that determines the length of the 
Yersinia injectisome needle. The ruler concept was taken from few known examples when 
one elongated protein determines the number of subunits of another protein polymerizing 
into a tubular structure, i.e. tail of bacteriophagues [91]. Similar mechanisms were 
proposed for the bacterial injectisome [92] and flagellar hook [93]. The protein YscP is the 
early substrate of the Yersinia export machinery, and is driven by two N-terminal export 
signal sequences. Since there is a linear dependence between lengths of the YscP helical 
domain and the formed needle, it was found that when the molecular ruler detects that 
needle has reached the final length its C-terminal domain switches the export machine 
substrate specificity to stop export of the YscF needle subunits [72, 92, 94]. 
 Outer rings (ring: YscC, chaperone: YscW) 
Secretins exist in the outer membrane as stable oligomeric complexes and were 
found in T3S and T2S system, type IV pilus and filamentous phage. The outer membrane 
of Yersinia is spanned by a triple ring of the YscC secretin, a unique membrane protein 
that forms the 12-14-meric ring structures of diameter ~110 Å [83, 95, 96]. Top view of 
the oligomer show large ring-like structures with an internal cavity that might function as 
an export channel. The C-terminus of YscC forms the trypsin-resistant domain, called 
secretin homology region, embedded in the outer membrane. The flexible N-terminus 
protrudes into the periplasmic space where it recognizes and binds inner membrane ring. 
Though C-terminal protease-resistant domain, predicted to be a β-barrel, is highly 
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conservative in all secretins, the N-terminal flexible domain shows much lower sequence 
homology. The low-resolution structure of PulD from K. oxytoca obtained in cryo EM 
revealed the approximate dimensions and localization of both domains [97]. Recently, the 
structure of N-terminal part of EscC, homolog of YscC, was solved [98]. 
 For correct localization and assembly, the YscC oligomer requires a specific 
lipoprotein, pilotin YscW [99]. In 2005, the crystal structure of MxiM (YscW homologue) 
shed light on the assistance in proper insertion and assembly of the oligomer. It was 
revealed that pilotin binds to the C-terminus helix of the secretin [100], protects the 
secretin against proteolysis and mediates its stable insertion into the bacteria outer 
membrane. In a PulD secretin, the PulS pilot protein remains associated with the outer 
membrane protein after its insertion into the lipid bilayer. Without the pilotin the PulD 
secretin is assembled in the inner membrane what highlights the importance of the 
lipoprotein. 
 Inner rings (ring: YscJ, connector: YscD) 
The inner membrane ring, called also MS (membrane spanning) ring, constituted 
by the YscJ and YscD proteins (homologues: Table 1.3) exhibits a bigger diameter than the 
rings in the outer membrane. It was reported that the large periplasmic homologue 
lipoprotein MxiJ is embedded in the inner membrane with its lipidated N-terminus and 
single C-terminal transmembrane helix [101]. So far, only the structure of EscJ was solved. 
In the crystal structure the individual proteins formed 24-subunits helical assembly [102]. 
Besides, the structure was fitted to the S. typhimurium basal body density map indicating 
that inner ring is made of 24 EscJ. Additionally, the rotational symmetry experiments of S. 
typhimurium injectisome suggested for the inner ring (PrgK) a 19-22-fold symmetry, in 
contrast to the S. flexneri (MxiJ) where side views of the needle complex correlated the 
best with the 24-fold symmetry. The stoichiometry of PrgK : PrgH : secretin (InvG) in S. 
typhimurium basal body has been proposed to be 22±1.7 : 17.4±1.4 : 13±1 assuming the 
secretin with 12-14 subunits as a reference [80]. On the other hand, when the MxiJ 
structure was docked into the cryo EM density map of the S. flexneri basal body it was 
suggested that the inner ring consists of 12 proteins [83].  
The YscD protein, much less conserved than YscJ, probably takes part in inner 
membrane ring formation and connects the YscJ with the YscC secretin [98].  
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 C ring (YscQ) 
 In the cryo EM reconstructions of the S. flexneri and S. enterica SPI-1 needle 
complexes the C ring was not observed [83]. However, it is known that YscQ protein has a 
high similarity to proteins FliN and FliM forming the 45-50 nm C ring in the flagellum and 
it is suspected to be an essential component in injectisome C ring. Data obtained from 
YscQ orthologs suggest the presence of a C ring in the lower part of the injectisome which 
would act as the platform for the ATPase complex [103]. 
 Export apparatus (transmembrane α-helical proteins: YscR, YscS, YscT, 
YscU, YscV, associated ATPase complex: YscN, YscK, YscL) 
 After formation of a Yersinia injectisome basal body five highly conserved proteins 
(YscR, YscS, YscT, YscU and YscV) are thought to form the translocation channel 
integrated in the inner and outer membrane rings. ATPase (YscN), associated with the 
transmembrane α-helical proteins was shown to interact with C ring (YscQ) and YscK and 
YscL proteins. ATPase, which is the conserved and essential inner membrane component 
in T3SS, is responsible for energizing the export apparatus. The recent structures of the 
flagellar ATPase and EPEC ATPase (EscN) pointed to the similarity of YscN with F1 
ATPase [104]. It is believed that the hexameric YscN is attached to the C ring of T3S pore 
with the central cavity filled with the protein that links it to the injectisome basal body. 
 
 
 
Figure 1.9: Electron micrograph with marked injectisome needles protruding from Yersinia 
enterocolitica [105]. 
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Figure 1.10: Model of the Yersinia Type III Secretion injectisome. Needle tip, needle, 
secretin YscC, MS ring, inner membrane (IM) proteins and ATPase with adequate proteins 
in the cytosolic ring (C ring) are highlighted. Model was based on [106]. 
1.3.3  Assembly of Yersinia injectisome 
Assembly of the Yersinia injectisome is a complex process that involves more than 
20 types of proteins, which form the structures in the outer and inner membranes (OM and 
IM), C ring and an external needle. Up to 2002, when it was proposed that the IM ring is 
formed first [107], little was known about the order of assembly of the complex. Recently, 
the new assembly model was confirmed [108], based on experiments with injectisome 
constituents fused to fluorescent proteins. It was found that the secretin ring in the outer 
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Yersinia membrane is formed first (Figure 1.11). It was also observed that the membrane 
ring-forming proteins (YscC, YscD, and YscJ) were required for the assembly of any 
cytosolic structure and that YscD was required for YscJ to become attached to YscC. After 
the outer and inner rings formation, the cytosolic components assemble onto the structure. 
Then the huge cytosolic complex made of ATPase (YscN, inactive), interacting proteins 
YscK and YscL and the component of C ring (YscQ) is formed independently on the 
export apparatus. However, it was confirmed that the C ring (YscQ) with its components is 
the integral part of the injectisome. 
 
 
 
Figure 1.11: Model of the assembly of the Yersinia injectisome taken from [108]. The 
formation of the injectisome starts at the YscC secretin ring in the outer membrane, 
followed by YscD and YscJ MS ring, and then the ATPase - C ring complex (YscN, K, L, 
and Q) assembled at the cytoplasmic side of the inner membrane. The assembly of IM 
proteins (YscR, S, T, U, and V) is not clear. At the very end the needle made of YscF 
subunits and tip (LcrV) is formed. 
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2 An approach to solve the structure of human 
Aquaporin 8 
 
Abstract 
 
Among the thirteen human aquaporins (AQP0-12), AQP8 is unique in the primary 
structure. By sequence alignment it is evident that AQP8 creates a separate subfamily, 
which is apart from all the other mammalian aquaporins. The special constriction region of 
the pore, which determines the solute permeability, is unique in AQP8 and makes it 
permeable to both ammonia and H2O2 in addition to water. For mammalian aquaporins, the 
structures solved up to now, all belong to the water-permeable subfamily. 
To better understand AQP8 selectivity and gating mechanism the high-resolution 
structure is necessary. To assess the structure, human AQP8 was overexpressed in 
methylotrophic yeast Pichia pastoris as a His-tagged protein. A wide screen of different 
detergents and detergent-lipid combinations for optimal protein purification and 2D-
crystalization was essential to obtain well-ordered AQP8 crystal arrays. Removal of amino 
acids constituting affinity tags was necessary to achieve highly ordered crystals diffracting 
up to 3 Å. Atomic force microscopy, electron microscopy and gold labeling experiments 
revealed the double-layered nature of 2D crystals, with tetrameric organization of AQP8, 
which had termini exposed outwards of the 2D crystal. In parallel, alignments to AQP4 
revealed a similar, extraordinary long N-terminal of AQP8. In analogy to AQP4, where 
only the short isoform is able to crystallize, 2D crystallization of the shorter AQP8 
construct, with removed N-terminus, was initiated.  
The protein expression, purification and 2D crystallization studies are part of the 
“Reconstitution of water channel function and crystallization of human aquaporin 8” 
manuscript of Maria Agemark Fellert1, Julia Kowal, Wanda Kukulski, Kristina Nordén1, 
Niklas Gustavsson1, Urban Johanson1, Andreas Engel and Per Kjellbom1. Described 2DX 
                                                
1 Center for Molecular Protein Science, Department of Biochemistry, Lund University, P.O. Box 124, SE-
221 00 Lund, Sweden 
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robot studies were presented in the publication “The 2DX robot: A membrane protein 2D 
crystallization Swiss Army knife” published in Journal of Structural Biology (see 
Appendix), 2010. 
2.1 Materials and Methods 
2.1.1  Expression of AQP8 in yeast Pichia pastoris and protein purification 
 Human AQP8 containing the c-myc epitope sequence and 6xHis-tag on the C-
terminal was heterologously overexpressed in the methylotrophic yeast Pichia pastoris. 
The protein expression in P. pastoris, membranes preparation and protein purification 
protocols were optimized in the laboratory of Per Kjellbom in Lund, Sweden.  
  To grow P. pastoris culture expressing the human AQP8 the BMGY (1% yeast 
extract, 2% peptone, 100 mM potassium phosphate buffer pH 6.0, 1.34% yeast nitrogen 
base without amino acids, 4x10-5 % biotin, 1% glycerol) was inoculated with the glycerol 
stock and incubated at 28°C, 200 rpm, to an OD600 of 5. Exchanging the medium to 
BMMY (1% yeast extract, 2% peptone, 100 mM potassium phosphate buffer pH 6.0, 
1.34% yeast nitrogen base without amino acids, 4x10-5 % biotin, 0.5% methanol) and 
increasing the volume 10 times induced the overexpression. Cells were pelleted, 
resuspended in BMMY and incubated in baffled flasks for 6 days (144 h) at 28°C, 200 
rpm. Because of evaporation and consumption, 0.5% sterile methanol was added every 24 
h. Cells were pelleted at 10000 g for 10 min and resuspended in breaking buffer (50 mM 
sodium phosphate buffer pH 7.4, 1 mM EDTA, 5% glycerol, 1 mM PMSF). Then cells 
were broken using the Bead Beater (BioSpec Products, USA) with a 50 ml chamber half-
filled with glass beads (0.5 mm ∅), by 12 runs of 30 seconds each and 30 seconds of 
cooling time in between. Cell debris was pelleted at 4000 g for 10 min at 4°C. Total 
membrane fraction was collected by the supernatant ultracentrifugation at 41000 g for 2 h, 
at 4°C. Membrane pellets were resuspended and homogenized in a cold buffer A (20 mM 
HEPES-NaOH pH 7.8, 50 mM NaCl, 10% glycerol, 2 mM ß-Mercaptoethanol, 0.03 % 
NaN3), aliquoted, frozen in the liquid nitrogen and stored at -80°C.  
 Crude P. pastoris membranes were diluted to a total protein concentration of 24 
mg/ml in the buffer B (20 mM HEPES-NaOH, 300 mM NaCl, 10% glycerol, 2 mM ß-
Mercaptoethanol, 0.03% NaN3) and solubilized dropwise with different detergents 
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solutions (4 % DDM, 6 % DM, 4 % Fos-choline12, 4% Cymal-6 in the buffer B to a final 
concentration of 2 % DDM, 3 % DM, 2% Fos-choline12 or 2% Cymal-6, respectively) to a 
final total protein concentration of 12 mg/ml. Membranes were solubilized for 3 h at room 
temperature with gentle stirring. The material that did not solubilize was pelleted at 
41000x g for 40 min at 4°C. Ni-NTA agarose (Qiagen) was equilibrated with buffer B with 
detergent (0.4% DM, 0.04% DDM, 0.15% Cymal-6 or 0.3% Fos-choline-12). 10 mM 
imidazole was added to the solubilized protein solution to minimize unspecific binding. 
For binding, the solution was incubated overnight with Ni-NTA agarose at 4°C. On the 
next day the slurry was placed into the PolyPrep column (BioRad) and washed with 50 bed 
volumes of buffer B with 70 mM imidazole and detergent. Aquaporin was eluted with 300 
mM imidazole in buffer B with detergent. Protein concentration was determined by 
measuring absorbance at 280 nm (MW = 29934.9 Da, ε280nm = 42970 M−1cm−1) [109], the 
purity and homogeneity of the sample were ascertained by 4-12% Bis-Tris NuPAGE 
(Invitrogen) and single particle EM. 
2.1.2 Single particles and sample homogeneity 
 Single particle grids were prepared by adsorbing 3 µl of purified protein solution at 
concentrations of 0.1 - 0.001 mg/ml for 30 sec - 1 min on carbon-coated copper grids 
previously rendered hydrophilic by glow discharging. Grids were washed four times with 
nanopure water and stained twice for 12 seconds with 2% uranyl acetate. Single particles 
were imaged with a Phillips CM-100 or CM-10 electron microscopes operated at 80 kV. 
2.1.3 Two-dimensional crystallization and endoprotease Lys-C treatment of 
2D crystals 
 Recombinant AQP8 solubilized in 2% DM and isolated by Ni-affinity 
chromatography was reconstituted into 2D crystals by dialysis. Purified protein ready for 
2D crystallization (1 mg/ml) was mixed with different lipids solubilized in 2% DM to 
achieve the final LPRs of 0.2, 0.3 and 0.4 (w/w). After one-hour preincubation at room 
temperature, 60 µl aliquots were dialyzed against a detergent-free buffer of varying 
composition in dialysis buttons using a dialysis membrane with a molecular cut-off of 10 
kDa. Different temperature profiles were tested. After 12, 24 or 36 h at room temperature 
dialysis buttons were moved to 37°C for 48 h and thereafter back to room temperature for 
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2 days. Subsequently, the best crystallization procedure was repeated and tuned in the 
temperature-controlled dialysis machine [110]. For cleavage of the C-terminal fragment 
containing His-Tag and c-myc epitope sequence, to each 100 µ l of AQP8-cmyc-His-tag 
sample 1 µg of Lys-C (Roche) was added after 36 h of the crystallization procedure. The 
serine protease Lys-C specifically cleaves peptide bonds C-terminally at lysine, at pH 7.0 – 
9.0. Reaction was stopped after the end of crystallization. The 2D crystals were washed 
twice through centrifugation at 5000 rpm for 10 min at 4ºC with subsequent removal of the 
supernatant and addition of fresh crystallization buffer solution.  
 An analog experiment was performed using endoprotease Glu-C (protease V8 from 
Staphylococcus aureus, Roche) that cleaves peptide bonds C-terminally at glutamic acid. 
  After the protease treatment, samples were analyzed by 4-12% Bis-Tris NuPAGE 
and western blot using TetraHis antibody (Qiagen). Briefly, after electrophoresis, gels 
were either stained by Coomassie brilliant blue R-250 or transferred to a polyvinylidene 
diflouride (PVDF) membrane at 100 V for 20 min. His-tags of AQP8 were detected by 
TetraHis antibody (Qiagen) diluted 1:2000 in Tris buffer saline and 3% bovine serum 
albumin. Anti-mouse IgG conjugated to alkaline phosphatase (GE Healthcare) was used as 
secondary antibody and the blots were developed with BCIP/NBT. 
 In parallel, the proper bands were cut out from the NuPAGE and send to the Mass 
Spectrometry Facility, Biozentrum, University of Basel [111] for analysis. Proteins 
isolated from the gel were digested with trypsin and resulting peptides were separated by 
capillary reverse phase chromatography coupled to the mass spectrometer. The masses of 
the peptides were measured and used for the protein fragments identification. 
Additionally, gold labeling experiments using 1.8 nm Ni-NTA-bound gold beads 
(Nanoprobes, [112]) were performed.  
2.1.4 Transmission electron microscopy and cryo electron microscopy 
 TEM was used for screening the crystallization trials. Grids were prepared as 
described in 2.2. Negatively stained specimens were imaged using a transmission electron 
microscope Phillips CM-100 or CM-10 operated at 80 kV. Electron micrographs were 
taken at magnifications of 7000x to 50000x and recorded on Kodak SO163 film or on a 
2000x2000 pixel charge-coupled device (CCD) camera (Veleta, Olympus soft imaging 
solutions GmbH, Munster, Germany) at a nominal magnification of 50000x (130000x at 
the plane of the CCD). 
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 Specimens of highly ordered AQP8 2D crystals were further analyzed by cryo EM. 
Selected samples were adsorbed on molybdenum grids coated with a carbon film, 
embedded in 7% trehalose [113] and frozen in liquid nitrogen. Electron micrographs were 
taken at low dose (<10 e¯ per Å2) at magnification of 50000x with a Phillips CM-200 FEG 
microscope operated at 200 kV and at the temperature of -175ºC.  
The electron diffraction patterns of 2D crystals were recorded at low electron doses   
(<5 e- per Å2) using a Philips CM200 FEG, operated at 200 kV, at temperature -175ºC, 
equipped with a Gatan UltraScan 1000 2000x2000 pixel slow scan CCD camera. 
2.1.5 Image Processing Library & Toolbox 
 Electron micrographs of 2D crystals were scanned with a Heidelberg Primescan 
D7100 drum scanner, at a step size of 5 µm (2000 lines/cm) resulting in a resolution of 1 
Å/pixel. Digitized images were analyzed and processed with the IPLT [114, 115]. Briefly, 
the goal was to filter an image, of a negatively stained 2D crystal and further, to improve it 
by correlation averaging. First, two data viewers displayed the image of double-layered 
crystal and its Fourier transform. To improve the display of the Fourier transform image 
was normalized. In the displayed Fourier transform peaks corresponded to two identical 
crystal lattices which originated from the double-layered crystal. One of the two lattices 
was fitted manually modifying the default Lattice Overlay option values. Because all the 
information about the unit cell was on the points in the lattice and everything outside the 
spots was a noise the image was filtered with a Fourier Peak Filter. In the perfect crystal, 
the information is concentrated on a single pixel. In reality, due to crystalline imperfections 
(i.e. crystal bending, crystal size), the information was spread out over several pixels. In 
the next step, correlation averaging, the created Fourier filtered image was used as a 
reference for a cross-correlation with the original image. The cross-correlation image 
displayed peaks correlated to the areas that were matching the template. By optimizing the 
Peak Search Parameters correct positions of the most unit cells in the image were found. 
The correlation peak positions were refined using a 2D Gaussian fit. The position 
information was used afterwards for averaging the unit cells and generating the averaged 
image. 
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Figure 2.1: Difference between electron diffraction and cryo EM images. (a-b) Electron 
diffraction pattern of protease Lys-C treated crystal. (c-f) Image processing performed 
using IPLT software. Orders 12 and 14 were highlighted in (b) and (c) with the red dashed 
line circles; (c) The Fourier-transformed image; (d) Lattice fitting performed on (c). The 
unit cell vectors are: α=β=133.5 Å, γ=90°; (e) Filtered and backtransformed image; (f) 
Correlation average with the unit cell contour. 
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2.1.6 Gold labeling of AQP8 crystals 
 Intact His-tagged AQP8 2D crystals, as well as crystals digested previously with 
endoprotease Lys-C (Roche), were dialyzed for 2 h at 4ºC against the buffer (20 mM Tris 
pH 8.0, 150 mM NaCl) without chelating and reducing agents, EDTA and DTT, 
respectively. 20 µl of protein crystal solution (0.5 mg/ml) was mixed with equal amount of 
1.8 nm Ni-NTA-bound gold beads (Nanoprobes [112]) of concentration 1 nmol/ml (Figure 
2.2). 20 µl-drops were applied on the carbon-covered copper grids, previously rendered 
hydrophilic by glow discharging, and incubated for 1 h. In parallel, control experiment 
crystal solutions were mixed and incubated on the grids with Ni-NTA-bound gold beads in 
the buffer containing 300 mM imidazole. Grids were washed four times with buffer 
containing 20 mM imidazole to eliminate only unspecific binding and stained twice for 12 
seconds with 2% uranyl acetate. Gold-labeled crystals were imaged with a Phillips CM-10 
electron microscope operated at 80 kV. 
 
 
Figure 2.2: Interaction between a His-tagged protein and 1.8 nm Ni-NTA-Nanogold [112]. 
2.1.7 Atomic force microscopy 
 A commercial atomic force microscope (AFM) (Nanowizzard II Ultra, JPK 
Instruments, Berlin, Germany) was used for imaging two-dimensional crystals of AQP8. 
The AFM was protected from vibrations by placing it on an active damping table. 
Furthermore, the instrument was shielded from acoustic noise. For AFM experiment the 
mica prepared as described in [116], freshly cleaned with Scotch tape, was used as support.  
The imaging was performed in buffer solution (100 mM NaCl, 20 mM HEPES-
NaOH, pH 7) at room temperature. All buffers were prepared using ultrapure water. For all 
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experiments rectangular silicon nitride cantilevers (ORC8-PS, knominal = 0.05 N·m-1, 
Olympus Ltd., Tokyo, Japan) were used. Two-dimensional crystals of reconstituted AQP8 
were adsorbed on a freshly cleaved mica surface in buffer solution (100 mM NaCl, 20 mM 
HEPES-NaOH, pH 7) for ~30 min at room temperature. Non-adsorbed material was 
removed by rinsing the sample several times with adsorption buffer. For imaging the 
adsorption buffer was used. Before imaging the membranes at forces <500 pN, the 
microscope was equilibrated to reduce cantilever drift. 
Piezo height images were analyzed using commercial software (JPK Image 
Processing Software, JPK Instruments, Berlin, Germany). 
2.1.8 Protein crystallization using 2DX robot 
 Crude membranes from Pichia pastoris expressing His-tagged AQP8 were 
solubilized with DDM and protein was purified as described in 2.2.1. 
 Purified protein (1 mg/ml) was dialyzed against crystallization buffer (20 mM 
Hepes pH 7.0, 100 mM NaCl, 5 mM EDTA, 10% glycerol, 2 mM DTT, 0.03% NaN3) for 
3 h at 4˚C. The protein was then mixed with selected lipids to final LPRs ranging from 0.2 
to 0.8 (w/w). In parallel to UV-spectroscopy measurements at 280 nm, the detergent 
concentration was measured with the DropBox [117]. 
 In a fully automated 2DX robot using the cyclodextrin-driven method for detergent 
removal (Figure 2.3) the kinetics of the reconstitution processes and temperature are 
precisely controlled. Moreover, the method requires smaller volumes and lower protein 
concentrations in comparison to other 2D crystallization methods. The 2D crystallization 
process was monitored by the light scattering intensity measurement. 
 The total ternary mixture volume was 30 µl, DDM detergent concentration was 
0.15% and the cyclodextrin titration rate ranged from 5 to 20 nl/(h µl). For crystallization, 
the following temperature profile was selected: 12 h at 23˚C, 12 h increasing linearly to 
37˚C, and 48 h at 37˚C. When proteins formed sheets and large vesicles, 0.3 µg of 
endoprotease Lys-C was added to remove a long, artificial C-terminus of protein. 
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Figure 2.3: Membrane protein 
crystallization robot [118]. (A) 
Contactless cyclodextrin dispenser. 
(B) Contactless volume measurement 
sensor. (C) Light scattering detector. 
(D) Contactless water dispenser 
maintaining the targeted sample 
volume. (E) An orbital microplate 
shaker allowing for simultaneous light 
scattering measurement provides 
homogenization of the crystallization 
mixture. (F) 96 wells commercial 
transparent microplate. A Peltier 
device regulates temperature.  
2.1.9 Cloning, transformation, expression and purification of new AQP8 
constructs 
 Cloning 
 The laboratory of Per Kjellbom, Sweden, kindly provided the pPICZΒ vector with 
the subcloned construct AQP8-cmyc-His-tag1. All designed reverse and forward primers 
(Microsynth) used for cloning experiments of the new constructs were diluted with 
nanopure water to the end concentration of 10 µM.  
Oligonucleotide primer sequences designed for 3 new constructs of AQP8, the 
template DNA and restriction enzymes used for cloning are shown in Table 2.1.  
 
                                                
1 In the AQP8 construct, provided by Per Kjellbom laboratory (Lund, Sweden) (AQP8-cmyc-His-tag) the 
first 5 amino acids from N-terminus are missing due to the used cDNA clone, which was the only one 
accessible on the market. The artificially added Ser2 was inserted for proper initiation of translation in Pichia 
pastoris. Thus, the original construct sequence starts with MSCEP while human AQP8 is MSGEIAMCEP. 
The amino acid numbering has been adjusted to the new construct - AQP8-cmyc-His-tag. 
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Table 2.1: New AQP8 constructs with physico-chemical parameters of a protein sequence 
[119], designed primers, the template DNA and restriction enzymes used for cloning. 
NEW CONSTRUCT PRIMERS 
TEMPLATE DNA  
(MODIFIED CONSTRUCT) 
RESTRICTION 
ENZYMES 
AQP8-TEV-cmyc-His-tag 
 
Number of amino acids: 288  
Molecular weight: 30566.6 Da  
Theoretical pI: 6.04  
 
Jul_Not_Xbafor 
5`-GGC CGC AGA AAA 
CCT GTA TTT TCA GGC T 
-3` 
Jul_Not_Xbarev 
5` - CTA GAG CCT GAA 
AAT ACA GGT TTT CTG C 
- 3` 
 
 
AQP8-cmyc-His-tag 
 
Number of amino acids: 283 
Molecular weight: 29934.9 Da 
Theoretical pI: 6.18  
 
XbaI / NotI 
 
AQP8-His-tag 
 
Number of amino acids: 265  
Molecular weight: 27915.7 Da 
Theoretical pI: 7.14 
 
 
Not_His_Xbafor 
5`- GGC CGC CAC CAT 
CAC CAT CAC CAT TGA 
CAT - 3` 
Not_His_Xbarev 
5`- CTA GAT GTC AAT 
GGT GAT GGT GAT GGT 
GGC - 3` 
 
AQP8-TEV-cmyc-His-tag XbaI / NotI 
 
MG18-AQP8-His-tag 
 
Number of amino acids: 249  
Molecular weight: 26168.8 Da 
Theoretical pI: 8.35 
 
 
N_modfor 
5` - CAG GGG AAT TCA 
AAA TGG GTG GCA GGT 
GGC GAG TGT C - 3` 
Not_His_Xbarev 
5`- CTA GAT GTC AAT 
GGT GAT GGT GAT GGT 
GGC - 3` 
 
AQP8-His-tag XbaI / NotI 
 
  
 Three new AQP8 constructs were designed:  
 
1. AQP8-TEV-cmyc-His-tag (AQP8 gene sequence with the inserted TEV protease 
cleavage site before the c-myc epitope sequence EQKLISEEDL and the 6xHis-tag 
on the C-terminus), 
2.  AQP8-His-tag (AQP8 gene sequence with the inserted 6xHis-tag on the C-
terminus),  
3. MG18-AQP8-His-tag (AQP8 gene sequence starting at Gly18 with the inserted 
6xHis-tag on the C-terminus). 
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The cloning strategy for AQP8-TEV-cmyc-His-tag and AQP8-His-tag constructs 
was based on the primers annealing, insertion of the modified DNA into the vector and an 
amplification of AQP8 gene with modified fragments in the pPICZΒ vector in E. coli. The 
procedure of annealing [120] involved the usage of a thermal cycler. 100 µl aliquots of the 
oligonucleotides mixed in PCR tubes were placed in the thermal cycler. The annealing had 
the following profile: heating to 95°C, 2 min at 95°C, ramp cooling to 25°C over a period 
of 45 minutes, a storage at temperature of 4°C. Template DNA digestion was performed 
with XbaI and NotI enzymes added at 37°C for 3h. The PCR product was purified using 
the QIAquick PCR Purification Kit, controlled by the agarose gel electrophoresis and 
stored at -20°C. The optimal ligation mix contained 12 µl of vector cut (10-50 ng), 5 µl of 
annealing product, 1 µl of T4 DNA ligase (Roche) and 2 µl of 10X T4 ligation buffer. The 
ligation was performed overnight at 16°C.  
 To the MG18-AQP8-His-tag construct a shorter N-terminus was introduced by the 
polymerase chain reaction (PCR) using designed primers and the construct AQP8-His-tag 
as the template. The PCR mix contained 15 ng of template DNA, 50 nM of forward and 
reverse primer, 1 µl of Pfu DNA polymerase, 2.5 µl of Pfu DNA polymerase buffer and 1 
µl of dNTP in a total reaction volume of 25 µl. The PCR was performed under the 
following conditions: 1 cycle of 30 sec at 95°C, then 20 cycles of 30 sec at 95°C, 30 sec at 
55°C and 5 min at 72°C, and 1 cycle of 10 min at 72°C. The PCR product was purified 
using the QIAquick PCR Purification Kit, controlled by agarose gel electrophoresis and 
stored at -20°C. 
 Plasmid transformation into E. coli cells using Heat Shock 
 50 µl competent DH5α E. coli cells were thawed onto wet ice with 5 µl of PCR or 
ligation product added. The mixture was incubated 30 min on ice, followed by 45 sec heat 
shock at 42°C and 1 min incubation on the ice. 950 µl of SOC or LB medium was added to 
the bacteria and the mixture was kept at 37°C, at 225 rpm, for 1 h to express the antibiotic 
resistance gene. 100 µl, 200 µl and 500 µl of transformed cells were plated on low salt LB 
plates containing 25 µg/ml of Zeocin and grown at 37°C overnight. 
 Plasmid linearization and sequencing 
 The plasmid isolation from transformed E. coli cells grown at 37°C overnight in 
liquid low salt LB medium was done using the Qiagen Miniprep Kit. 170-350 ng of 
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isolated DNA was mixed with 1 µl of sequencing primer, 2 µl of BigDye-Premix Version 
3.1 solution, 2 µl of 5X Sequencing buffer Version 3.1 in a total reaction volume of 10 µl 
and amplified in the thermal cycler under the following conditions: 30 cycles of 10 sec at 
96°C and 4 min at 55°C, then cooled to 4°C. DNA, purified using the QIAquick PCR 
Purification Kit, was mixed with 1 µl of 125 mM EDTA and 2 µl of 3M sodium acetate, 
then with 50 µl of ethanol and incubated for 15 min on the ice. DNA was pelleted at 10000 
rpm, at 4°C, for 10 min and the pellet was washed with 400 µl of 70% ethanol. Prepared 
dry DNA pellet was sent and sequenced in the Microsynth. The E. coli plasmid 
linearization was achieved by PmeI digestion at 37°C for 3h and controlled by agarose gel 
electrophoresis. The linearized DNA was purified using the QIAquick PCR Purification 
Kit. DNA was eluted in 100 µl of nanopure water to eliminate all salts and prevent an 
arching (electrical discharge), which reduces the viability of cells when pulsing the Pichia 
pastoris cells. 
 Transformation of Pichia pastoris cells 
 X-33 Pichia pastoris cells were grown on YPD plates at 30°C for 48 h. Colonies 
were scratched from plates and grown in 5 ml of YPD liquid medium overnight at 30°C, at 
200 rpm. 200 ml YPD were inoculated with 2 ml of the overnight culture and grown to an 
OD600 of 1.6. Cells were pelleted at 4000 rpm for 10 min at 4°C, resuspended in 120 ml of 
the sterile, ice-cold water, pelleted, again resuspended in 60 ml of the sterile, ice-cold 
water, pelleted, resuspended in 5 ml of sterile, ice-cold 1M sorbitol, pelleted, resuspended 
in 0.3 ml of sterile, ice-cold 1M sorbitol and kept on ice. 100 µl of P. pastoris 
electrocompetent cells were mixed with 5 µl of purified DNA (0.5-1 mg/ml), incubated for 
5 min on ice and transferred to the ice-cold 0.2 cm electroporation cuvette. The yeast 
electroporation was performed in the GenePulser apparatus (Bio-Rad) and the following 
parameters were applied:  charging voltage = 1500 V, capacitance = 25 µF, resistance = 
200 Ω . Immediately after the application of 1 pulse 1 ml of sterile, ice-cold 1M sorbitol 
was added to the cuvette with DNA/cells. Transformants were incubated for 2 h at 30°C, 
afterwards 150-200 µl of cells were plated on the YPD plates with 100, 200, 500 and 1000 
µg/ml Zeocin and incubated at 30°C, in darkness, for 3-5 days. Yeast clones with the 
highest Zeocin resistency were grown on YPD plates containing 200 µg/ml Zeocin, at 
30°C for 2 days. Yeast colonies were picked and cultured in 5 ml of liquid YPD medium at 
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30°C, overnight. 0.2 ml of sterile 80% glycerol was added to yeast culture aliquots of 0.8 
ml in sterile eppendorfs. P. pastoris glycerol stocks were frozen and stored at -80°C. 
2.1.10 Purification and 2D crystallization of new AQP8 constructs 
 All 3 new AQP8 constructs were designed to have 6xHis-Tag on the C-terminus, 
therefore the protein was purified according to the same protocol as AQP8-cmyc-His-tag 
construct as described in 2.1.1. An additional purification step occurred only for the 
construct with a TEV protease cleavage site.  
  The Tobacco Etch Virus (TEV) protease, 27 kDa, is a highly site-specific cysteine 
protease encoded by TEV and is often used for removing affinity tags from purified 
proteins. Protease recognizes a linear epitope of the general form of E-Xaa-Xaa-Y-Xaa-Q-
(G/S) where the cleavage occurs between the Gln and Gly/Ser residues. The most efficient 
substrate for hydrolase is ENLYFQS [121], although it was shown that many different 
amino acids can be placed in the P1’ position [122], what has relatively small impact on 
the enzyme efficiency. In the construct AQP8-TEV-cmyc-His-tag the protease recognition 
site is ENLYFQA and the proteolysis occurs between Gln and Ala residues. The pure His-
tagged form of TEV protease was obtained from self-processing MBP-TEV fusion protein 
[123]. After the purification on Ni-NTA agarose 1 mg of the construct AQP8-TEV-cmyc-
His-tag was mixed with 20 mg of the His-tagged TEV protease and dialyzed overnight in 
the Slide-A-Lyzer Cassette (Pierce) with 10 kDa molecular mass cut-off against the elution 
buffer, without imidazole, at 4°C. The His-tagged protease and removed His-tagged C-
terminus of protein were bound to the Ni-NTA by vigorous shaking for 1 h at 4°C and the 
resin was collected on the PolyPrep column (Bio-Rad). The flow-through contained the 
protein which purity was determined by 4-12% Bis-Tris NuPAGE and the concentration 
by measuring absorbance at 280 nm. 
The purified protein fractions of all constructs were kept for 2 days at room 
temperature and at 4°C to study the protein stability. Samples were ultracentrifuged at 
150000 g and supernatants analyzed by NuPAGE. No visible pellet of possible precipitated 
protein was observed after ultracentrifugation and no protein degradation was detected 
using the gel. Single particles homogeneity and monodispersity were checked by negative 
stain EM. 
 Screening for 2D crystallization conditions and protein crystallization of new 
constructs was performed according to the protocol described in 2.1.3. Briefly, the pure 
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protein was mixed with DM-solubilized E. coli polar, DMPC or phosphatidyl lipids at 
protein end concentration of 0.5-1 mg/ml. The detergent removal from the protein-lipid-
detergent ternary mixture was achieved by the 4-day long dialysis in dialysis buttons 
against crystallization buffers. The temperature profile was as follow: 36 h at room 
temperature, 48 h at 37°C and 24 h at room temperature. Crystal presence and quality were 
checked using the negative stain EM. 
 
2.2 Results 
2.2.1 Expression of AQP8 in yeast Pichia pastoris and protein purification  
The clone of yeast Pichia pastoris heterologously expressing human AQP8 
(construct AQP8-cmyc-His-tag), as well as the culturing, membrane preparation and 
protein purification protocols were established by M. Fellert from the laboratory of Per 
Kjellbom in Lund, Sweden. 
144-hour long yeast expression was crucial to obtain the adequate total membrane 
protein content. Crude membranes were directly solubilized with selected detergent 
omitting the alkaine/urea stripping protocol that is used to remove membrane-associated 
proteins [124], which led to a huge loss of AQP8 protein. M. Fellert and W. Kukulski 
performed a wide screen of 9 different detergents and, after comparison of the purification 
efficiency in a quantitative manner, it turned out that the best-solubilizing AQP8 detergents 
are DM, DDM, Cymal-6 and Fos-choline-12 (unpublished results, Figure 2.4, Figure 2.5). 
Depending on the 2D crystallization method the protein was solubilized both in the low 
and high CMC detergents (Table 2.2). For the dialysis technique, typically, the high CMC 
detergent (DM) was used. For crystallization in an automated 2DX robot the protein was 
purified in DDM.  
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Table 2.2: CMC and concentrations of detergents used for solubilization and purification 
of the AQP8. 
DETERGENT CMC [%] 
 
SOLUBILIZATION 
CONCENTRATION 
[%] 
 
WASH AND ELUTION 
CONCENTRATIONS [%] 
DM 0.087 3 0.4 
DDM 0.0087 2 0.04 
Cymal-6 0.028 2 0.15 
Fos-choline-12 0.053 2 0.3 
 
 
Extending the solubilization time from 2 to 3-4 hours at room temperature 
increased the AQP8 solubilization yield twofold. Efficient purification by Ni-NTA affinity 
chromatography routinely gave a single fraction of highly pure AQP8. Concentration of 
the eluted His-tagged AQP8 was typically 2 – 4 mg/ml making it possible to set up 2D 
crystallization trials at the protein concentration of 1 mg/ml. With the optimized protocol 
on average 1 – 2 mg of pure protein was obtained from 1 l of P. pastoris culture. 
 
 
Figure 2.4: SDS-PAGE showing test purification with the four best detergents. Wash 
fractions collected after 3, 20 and 40 ml (W3, W20, W40) and elution fractions E1-3 are 
shown. 
 
Single particles homogeneity was checked by negative stain EM. Electron 
micrographs were taken at a magnification of 50000x and a top view class average was 
calculated from 490 particles in EMAN software package. The evident 4-fold symmetry of 
the purified AQP8 complex confirms its tetrameric nature, which is typical for all known 
aquaporins. 
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Figure 2.5: Electron micrographs of negatively stained single AQP8 particles purified in 
DM (a) and in DDM (b). The inset (provided by W. Kukulski) shows a top class average 
calculated from 490 DDM-purified particles. Scale bars correspond to 20 nm in (a-b) and 5 
nm in the inset (c). 
2.2.2 Two-dimensional crystallization of AQP8 
 Crystallization conditions optimization 
To optimize crystallization, a variety of conditions were tested: a range of LPRs, 
different lipids, detergents, and buffers at various pH values as well as different salts with 
varying concentrations. Solubilized and highly purified AQP8 was reproducibly 
reconstituted into lipid bilayers using a mixture of POPE and POPC lipids (Figure 2.6) in 
the ratio of 3:7 (w/w). Mixtures of POPA:POPE:POPC lipids or DOPA:DOPE:DOPC 
lipids, both in ratio 1:2:7, gave equally good results. E. coli polar lipids were tested as well, 
but only small vesicles with a diameter in the order of 100 nm, were found. Neither 
POPS:POPC lipids (in ratio 3:7) nor pure DOPC turned out to be useful. In the first case, 
formation of small tubes, collapsed vesicles and aggregated structures were observed, 
whereas in the second case only aggregates and precipitations were noticed. 
High protein concentrations during crystallization resulted in well-ordered 2D 
crystals. The optimal protein concentration was 1 mg/ml for which the best LPR was 0.25-
0.3. Optimal NaCl concentration in the dialysis buffer was between 100 mM and 250 mM. 
Ordered crystals of AQP8 were obtained at pH 7.0. In the pH range between 7.4 and 8.4 
the crystals were smaller and mixed with aggregates. At pH 4.0 and 9.0 the protein 
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precipitated, also at pH 5.0 and 6.0 a significant number of aggregates was observed. 
Therefore all further crystallization trials were performed at pH 7.0. 
Addition of EDTA to the dialysis buffer reduced the aggregation observed in the 
presence of the divalent cations Mg2+ and Ca2+. Nevertheless, aggregates occurred both in 
the absence and presence of divalent cations (Figure 2.7 c-d). 
During the AQP8 crystallization process the temperature profile had a significant 
influence on the formation, size, and quality of the crystals. For instance, tubular crystals 
occurred when dialysis buttons were moved to the higher temperature during the first 36 h 
of crystallization. In contrast, incubation at room temperature for the first 36 h and 
subsequent temperature increase yielded large amounts of regularly packed sheets and 
vesicles-like structures of a few micrometers in size. Interestingly, the quality of AQP8 2D 
crystals improved during a two-week long storage at 4°C.  
To precisely control the crystallization, most of the experiments were carried out in 
the temperature-controlled dialysis machine. The following temperature profile was 
selected: 12 h at 20ºC, 12 h linear increase to 37ºC, 48 h at 37ºC, and 24 h linear decline to 
20ºC. 
Optimal 2D crystallization conditions had the following parameters (Table 2.3):  
POPE/POPC lipids (in ratio 3:7), LPR of 0.25-0.3 and the dialyzing buffer containing 
20mM HEPES-NaOH pH 7.0, 100 mM NaCl, 5 mM EDTA, 2mM DTT and 10% glycerol. 
 
 
Figure 2.6: Models of (a) POPC, (b) POPE, (c) POPS and (d) POPG lipids. Colors 
correspond to: yellow – 1-palmitoyl chain, gray – 2-oleoyl chain, green – carbon, red – 
oxygen, orange - phosphorus, blue – nitrogen and white – hydrogen atoms in –PX head 
group.  
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 Analysis of a projection map of intact AQP8 
A large variety of different 2D crystallization conditions resulted in diverse protein 
packing arrangements in reconstituted lipid bilayers and number of 2D crystal lattice 
parameters. Electron micrographs of negatively stained reconstituted samples revealed 
long and rather thin tubular structures (Figure 2.7 a-b), vesicles and also well-ordered 2D 
crystalline sheets with a diameter of 2 µm and a length of several micrometers (Figure 2.7 
e).  
The unit cell vectors of tubular crystals, which were less ordered than sheets, were 
determined to be a = b = 100 Å and γ = 90° with 8 monomers per unit cell. The unit cell 
vectors of sheets grown in buffer containing 100 mM NaCl were a = b = 72 Å, γ   = 90° 
(crystals exhibit a p4 symmetry and accommodate 1 tetramer per unit cell; Figure 2.7 g), 
and in 1 M NaCl were a = 68.5 Å, b = 133 Å, γ  = 100° (two tetramers per unit cell, up–
and–down orientation), respectively. 
In the majority of cases, the power spectra showed two sets of diffraction spots 
indicating two crystalline layers or collapsed vesicles (Figure 2.7 f). The two lattices, 
which happen to be rotated by 65°, were analyzed separately with the IPLT software 
package [114]. The 2D projection map of AQP8 shows individual monomeric pores in a 
tetrameric organization with a well visible central depression (Figure 2.7 g). 
 
Figure 2.7: 2D crystals of AQP8 were reconstituted by dialysis in the presence of lipid. (a) 
Crystals appear as well ordered tubes with a diameter of about 360 nm and a length of 
several micrometers, often attached to aggregates, vesicles or unrolled/open tubes. (b) 
Crystalline AQP8 tubes at a magnification 50000x. (c) Crystals after addition of 5 mM 
EDTA appear as large vesicles and sheets of regularly packed protein. (d) 2D crystals in 
the presence of Mg2+ appear as small vesicles or tubes that often clustered together. (e) 
Overview of a large crystal obtained under the optimized conditions. The double-layered 
crystals are large mono-crystalline protein-lipid arrays. (f) The power spectrum calculated 
from cryo EM image of crystalline sheet shown in (e) reveals two sets of diffraction spots 
indicating a double-layered crystal. Sharp diffraction spots marked by white arrow extend 
to the order (9,3) corresponding to a resolution of 8 Å. Point marked by an arrowhead 
corresponds to a resolution of 12 Å. (g) The 2D projection map calculated from a cryo 
electron micrograph. AQP8 packs into arrays with p4 symmetry, housing one tetramer per 
unit cell of size 72 Å. The dark areas between bright protein tetramers represent the lipid 
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bilayer. (h) Electron micrograph of a negatively stained Lys-C treated crystals. The large 
well-ordered rectangular double-layered crystals, with sizes of several micrometers in 
diameter are visible. (i) The electron diffraction pattern of a frozen–hydrated crystal 
showed in (h). On insert sharp diffraction orders marked by black arrow correspond to a 
resolution of 3 Å, by the arrowhead to 3.3 Å. Scale bars corresponds to 1 µm in (a, c-e), 
200 nm in (b), 50 Å in (g) and 5 µm in (h). 
 
Table 2.3: The summary of 2D-crystallization experiments. 
PARAMETER RANGE TESTED 
OPTIMAL 
CONDITION 
Detergent DM, DDM, Cymal-6, Fos-choline12 DM 
Lipids 
E. coli, E. coli polar, soy, liver, brain, DMPC, DOPS, DOPE, 
DOPC, DOPA, POPS, POPC, POPE, POPA, POPE:POPC 
(1:1, 3:7), POPS:POPC (3:7), POPA:POPE:POPC (1:2:7), 
POPA:POPC (1:1, 3:7), DOPE:DOPC (3:7), DOPS:DOPC 
(3:7), DOPA:DOPC(1:1, 3:7), DOPA:DOPE:DOPC (1:2:7) 
POPE:POPC (3:7) 
LPR 0.1 - 1.3 0.25 - 0.3 
Protein concentration 0.5 - 2 mg/ml 1 mg/ml 
pH 4.0 - 9.0 7.0 
Buffer Citrate, MES, Hepes, Tris Hepes 
NaCl 50 mM - 1M 100 mM 
MgCl2 0 - 20 mM - 
CaCl2 0 - 20 mM - 
EDTA 0 - 5 mM 5 mM 
DTT 0 - 10 mM 2 mM 
Glycerol 0 - 20% 10% 
Temperature profile 4°C, 20°C, 37°C, 20°C→37°C, 20°C→4°C, 20°C→4°C→20°C, 20°C→37°C→20°C, 37°C→20°C 20°C→37°C→20°C 
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2.2.3 Atomic force microscopy of double-layered crystals 
Intact 2D crystals of AQP8 adsorbed without wrinkles to the mica and were 
suitable for imaging by AFM. The overview in Figure 2.8 demonstrates the double-layered 
2D crystal, whose thickness was measured to be 12 nm. Crystals often stacked and formed 
the multilayer structures made of 2 or 3 double-layers with heights of 24 or 36 nm, 
respectively.  
 
 
 
  
Figure 2.8: (a) AFM topograph of AQP8 2D crystals adsorbed to mica and recorded in 
buffer solution: 20 mM HEPES pH 7.0, 100 mM NaCl, 5 mM EDTA. Multi-layered areas 
can be clearly distinguished from double-layered crystals by their height above the mica 
surface. (b) Cross section analysis along the blue dashed line in the image (a). (c) Cross 
section analysis along the white dashed line in image (a). 
2.2.4 Lys-C protease treated 2D crystals  
 2D crystallization with addition of the Lys-C protease  
The AQP8 construct contains a 10 aa long c-myc epitope (EQKLISEEDL), 6xHis-
tag and 11 aa long linkers at the C-terminus of the protein (Figure 2.14 a). It was suspected 
that this 27 aa sequence could possibly disturb crystallization. Therefore the fragment was 
removed enzymatically during the dialysis procedure. The 283 aa long AQP8 construct has 
7 Lys-C cleavage sites (K11, K124, K175, K177, K248, K254 and K265). When the 
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protein was embedded in a lipid bilayer, theoretically all of these Lys were exposed to the 
enzyme except one located in the transmembrane helix 3 (K124). One Lys is positioned in 
the N-terminal region (K11), 2 Lys in the cytosolic D-loop (K175, K177) and 3 Lys in the 
C-terminal region of AQP8 (K248, K254, K265). However, it was assumed that lysines at 
the D-loop are hidden and inaccessible for the enzyme. 
Addition of the Lys-C serine protease during the crystallization process resulted in 
formation of large rectangular protein-lipid arrays (Figure 2.7 h), instead of the round 
sheets and vesicle-like structures (Figure 2.7 c-e). The lattice parameters of Lys-C treated 
crystal were a = b = 133.5 Å, γ  = 90°. The correlation average of Lys-C digested crystal 
was shown on Figure 2.9.  
The Philips CM200 FEG was aligned according to the standard protocol for 
electron diffraction. Diffraction patterns of digested crystals recorded with a CCD camera 
at tilt angle 0˚, showed sharp spots at 3 Å, however, blurred diffraction spots were also 
visible at higher resolution. The two orders, marked by black arrow and the arrowhead in 
Figure 2.7 i, correspond to a resolution of 3 Å and 3.3 Å, respectively. 
 
 
 
 
Figure 2.9: Correlation average of Lys-C digested 2D crystal. For cryo EM experiments 
crystals were embedded in 7% trehalose. Low-pass (10 Å) and high-pass (200 Å) 
thresholds were applied during IPLT processing. Unit cell vectors are a = b = 133.5 Å, γ  = 
90°. Scale bar corresponds to 100 Å.  
 
Mass spectroscopy measurements of Lys-C protease digested crystals showed that 
removal of first 10 amino acids of N-terminus was achieved.  However, neither His-tag nor 
any 11 aa or 18 aa peptide, corresponding to the potential fragments on the C-terminus, 
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could be identified. Therefore, two additional experiments were performed on 2D crystals: 
gold labeling using 1.8 nm Ni-NTA-bound gold beads (Nanoprobes), able to bind to the 
His-Tags, and Western blot with Tetra-His antibody (Qiagen). 
 Gold labeling of Lys-C treated crystals 
To detect if His-tags are exposed on the surface of the double-layered crystal, 1.8 
nm-Ni-NTA-bound gold beads were mixed with intact and Lys-C digested 2D crystals 
dialyzed previously against the binding buffer (20 mM Tris-HCl pH 8.0, 150 mM NaCl) 
without chelating (EDTA) and reducing (DTT) agents. After 1 h incubation of samples on 
the carbon-coated grids, each grid was washed with 20 mM imidazole to remove all 
unbounded gold particles. As shown on electron micrographs in Figure 2.10, only single 
gold particles sparsely appeared in the background. In control experiment, with 300 mM 
imidazole in the binding buffer, Ni-NTA-bound gold beads did not bind to the His-tagged 
crystals. 
Surprisingly, Ni-NTA-bound gold particles had attached to the crystal surface, not 
only in the case of the intact but as well to the Lys-C treated crystals (Figure 2.10 a-d). 
Additionally, more gold particles were bound to the digested crystal surface in comparison 
to the intact ones. When the enzyme concentration had been increased from 0.005 mg/ml 
to 0.01 mg/ml (from ratio 1:200 to 1:100 (w/w)), number of gold particles bound to the 2D 
crystal even increased revealing densely packed gold-particles patches (Figure 2.10 e-f).  
The results indicated that cytosolic AQP8 termini of both layers are exposed 
outwards of the double-layered crystal. Additionally, the result demonstrates that the 
removal of His-tags localized on the crystal surface, was not complete. Attachment of 
larger number of Ni-NTA-bound gold beads to the digested crystals suggests that at first 
10 aa on the N-terminus of the protein are removed and then the His-tagged C-terminus, 
which is not easily accessible for protease, is being exposed.  
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Figure 2.10: Gold labeling of AQP8 crystals. Black dots correspond to Ni-NTA-bound 
gold beads. (a-b) Intact crystals, (c-d) Crystals incubated with protease in ratio 1:200 
(w/w), (e-f) Crystals treated with Lys-C in ratio 1:100 (w/w). Scale bars correspond to 100 
nm in (a, c, e) and to 20 nm in (b, d, f). 
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 Western blot with Tetra-His antibody 
 Western blot was performed in parallel to SDS PAGE. Intact, Lys-C and Glu-C 
treated AQP8 2D crystals were mixed with denaturating SDS-PAGE buffer and proteins 
were separated on the NuPAGE. After the protein transfer on the PVDF membrane, the 
Tetra-His antibody (Qiagen) for highly specific and sensitive detection of 6xHis-tag was 
attached to the C-terminal His-tagged proteins. The secondary antibody was conjugated to 
the alkaline phosphatase. The phosphatase hydrolyzed a substrate BCIP to form a blue 
intermediate that was then oxidized by NBT to produce a dimer of an intense insoluble 
purple dye. The western blot visualized His-tags present in protein or peptides (Figure 
2.11).  
In Figure 2.11, the image (c) which is the superimposed image (a) onto (b), 
revealed that a small percentage of protein in the sample with intact crystals was 
degradated from C-terminus (Figure 2.11, lines 1-2). Moreover, it turned out that after 
addition of the Lys-C protease during crystallization the first 10 aa from N-terminus were 
removed completely but some His-tags were inaccessible for enzyme (Figure 2.11, line 3). 
When the ratio enzyme:AQP8 was 1:100 (w/w) and the crystals diffracting to 3 Å formed, 
additional bands were observed on the SDS gel around 10 kDa and 15 kDa. This suggested 
that the cytosolic D-loop of 50% of all AQP8 (Figure 2.14 a) was cut by the protease on 
K175 or K177 (Figure 2.11, line 4). Because the enzyme was added to the protein 
reconstituted in the membrane, only exposed D-loops could have been fragmented. 
Amazingly, only ~75% of His-tags were accessible for Lys-C protease even after 
increasing enzyme:AQP8 ratio.  
In crystals digested with a Glu-C protease, which hydrolyses peptide bonds on Glu, 
100% of C-termini were removed (Figure 2.11, line 5) but when amount of enzyme was 
increased to a ratio of 1:100 (w/w) additional bands were visible on the gel (Figure 2.11, 
line 6) analogously to Lys-C treated crystals (Figure 2.11, line 4) suggesting that protein 
was cut by the enzyme on E174. Crystals formed during crystallization with Glu-C had 
much worse quality than those treated with Lys-C. 
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Figure 2.11: (a) NuPAGE and (b) Western blot of AQP8 2D crystals. Image (c) 
corresponds to superimposed image (a) onto image (b). In (b) Tetra-His antibody for 
detection of C-terminal 6xHis-tag was used. First line corresponds to protein molecular 
weight marker (Odyssey). Lines marked as 1-2 correspond to intact crystals, 3-4 to crystals 
treated with Lys-C protease in ratio 1:200 and 1:100 (w/w), respectively, 5-6 to crystals 
treated with Glu-C protease in the same manner.  
 IPLT 
 Symmetrically arranged stripes were observed on the diffraction patterns of AQP8 
2D crystals that were treated with Lys-C protease. These lines, always 2-orders long and 
occuring both at low and high resolution, were examined using the IPLT software [114] 
(Figure 2.12).  
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Figure 2.12: To observe what the stripes on the diffraction pattern (a) of Lys-C digested 
AQP8 crystal correspond to, the lines between orders (4, 1) and (4, -1) etc., highlighted by 
red dashed line circles, were selected in parallel to the peak information in a lattice and 
Fourier-backtransformed in IPLT. (b) Filtered and backtransformed image (peaks in the 
lattice). Four AQP8 overlapped from two crystal layers were highlighted with blue dashed 
line squares. (c) Filtered and backtransformed image (peaks plus lines from red dashed line 
circles in the lattice). 
 
 The Fourier-filtered and backtransformed image of AQP8 2D crystal represents 
two overlapped crystal layers adhering exactly to each other. The most conspicuous is the 
repetitive motive of 4 AQP8 overlapped from both layers and arranged at the corners of the 
square (Figure 2.12 b). In the backtransformed image where lines between spots were 
included to the lattice (Figure 2.12 c), the proteins located in between those 4 anchored 
aquaporins look more blurred or disordered in comparison to the normal backtransformed 
image. That indicates that the lines visible on the diffraction pattern originate from 
systematic crystal structure disorder, which could be connected with proteolysis of peptide 
bond at the D-loop.  
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The crystal disorders, which are likely the result of AQP8 proteolysis by Lys-C, led 
to distortions of diffraction pattern and made these crystals unsuitable for generating three-
dimensional model at high resolution. For this reason, new AQP8 constructs were 
designed. 
2.2.5 The 2DX robot: A membrane protein 2D crystallization Swiss Army 
 knife 
The crystallization conditions of the human aquaporin AQP8 solubilized in DDM 
were screened using the 2DX robot. AQP8 was reconstituted as double-layered crystalline 
sheets and packed vesicles of a few micrometers in diameter. As illustrated in Figure 2.13, 
the 2D crystals developed during gradual detergent neutralization by cyclodextrin from the 
ternary protein–lipid–detergent mixture over 60 h. The reconstitution process was 
monitored using the light scattering (Figure 2.13 F). By taking samples after 5, 11, 21 and 
26 h (Figure 2.13 A, B, C and D, respectively), we could demonstrate how the 
crystallization kinetics influences crystal growth. To explore the effect of the reconstitution 
kinetics with AQP8, parallel experiments were run over 60 h, while the detergent removal 
rates were varied from 1 to 4 folds (5, 10, 15 and 20 nl/(h•µl)). When the 36 mM 
cyclodextrin solution was added at a rate of 20 nl/(h µl) to the crystallization mixture 
containing 3 mM detergent (DDM) and AQP8 at a concentration of 1 mg/ml, small 
proteoliposomes were formed. In contrast, large sheets were detected during 
reconstitutions at a rate of 5 nl/(h•µl) (Figure 2.13 E). Moreover, the effect of removing the 
6xHis-tag of AQP8 with the protease Lys-C was explored at different stages of AQP8 
reconstitution. Lys-C was added to improve the crystallinity of giant vesicles that formed 
when the reconstitution process was well advanced (Figure 2.13 D). If the protease was 
added too early, aggregation occurred. Best results with DDM solubilized AQP8 were 
obtained upon cleavage of the C- and N-terminal moiety by enzyme addition when 
proteins formed sheets and large vesicles. Diffraction patterns exhibited spots beyond 4 Å 
(highest observable Friedel pairs) (Figure 2.13 G). The temperature profile (12 h at 23˚C, 
followed by a slope reaching a plateau at 37˚C 12 h later) was the key to obtaining highly 
ordered AQP8 sheets.  
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Figure 2.13: Electron micrographs of negatively stained samples taken at different stages 
during crystallization of AQP8. [118] (A) After 5 h, sufficient cyclodextrin has been added 
to neutralize all the free detergent molecules and small proteoliposomes started to 
assemble. (B) After 11 h, sheets and vesicles coexist. (C) After 21 h, sheets are more 
numerous while the number of vesicles has decreased. (D) After 26 h giant vesicular 
structures are found, but their morphology does not indicate crystallinity. (E) After 
addition of more cyclodextrin and Lys-C endoprotease, crystalline sheets are observed at 
59 h. Scale bar is 200 nm for (A), 400 nm for (B) and (C), 800 nm for (D), and 3 µm for 
(E). (F) Light scattering profile indicates the reconstitution progress. Samples for 
micrographs shown in (A)–(E) have been taken at time points indicated by arrows. (G) 
Cryo electron diffraction of crystals shown in (E). Spots marked by a circle correspond to a 
resolution of 3.3 Å. Scale bar is 2 nm-1. 
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2.2.6 Production and 2D crystallization of new AQP8 constructs 
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Figure 2.14: Schematic topology of different AQP8 constructs drawn by the TOPO2 
software [125]. (a) Construct provided by P.Kjellbom laboratory, Sweden, AQP8-cmyc-
His-tag, (b) AQP8-TEV-cmyc-His-tag, (c) AQP8-His-tag, (d) MG18-AQP8-His-tag. The 
colors corresponds to: orange – artificial added amino acids (i.e. Ser2 included in P. 
pastoris start codon, TEV, c-myc or 6xHis-Tag), red – 7 lysines, black – 2 conserved 
NPA-boxes, blue – conserved amino acids in the protein constriction region (from the N-
terminal called H2, LC, H5, LE1, LE2 and LE3), gray – cysteine responsible for mercury 
inhibition.  
 
The difficulty in reaching suitable 2D crystals for atomic scale electron 
crystallography with the initial AQP8 construct was explained by the too long artificial C-
terminus of the protein. Thus 3 new shorter AQP8 constructs were designed and 
introduced into the yeast genome. Until now expression in P. pastoris and 2D 
crystallization trials were performed on two of them (AQP8-TEV-cmyc-His-tag and 
AQP8-His-tag), and the best results were obtained for AQP8-His-tag. 
 
 Cloning, Pichia pastoris electroporation, expression and screening for best 
expressing clones 
The laboratory of Per Kjellbom, Sweden, kindly provided the pPICZΒ vector with the 
subcloned construct AQP8-cmyc-His-tag2 (Figure 2.14 a). Three new AQP8 constructs 
were designed (Figure 2.14 b-d):  
 
1. AQP8-TEV-cmyc-His-tag (AQP8 gene sequence with the inserted TEV protease 
cleavage site before the c-myc epitope sequence EQKLISEEDL and the 6xHis-tag 
on the C-terminus), 
                                                
2 In the AQP8 construct, provided by Per Kjellbom laboratory (Lund, Sweden) (AQP8-cmyc-His-tag) the 
first 5 amino acids from N-terminus are missing due to the used cDNA clone, which was the only one 
accessible on the market. The artificially added Ser2 was inserted for proper initiation of translation in Pichia 
pastoris. Thus, the original construct sequence starts with MSCEP while human AQP8 is MSGEIAMCEP. 
The amino acid numbering has been adjusted to the new construct - AQP8-cmyc-His-tag. 
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 2. AQP8-His-tag (AQP8 gene sequence with the inserted 6xHis-tag on the C-
terminus),  
3. MG18-AQP8-His-tag (AQP8 gene sequence starting at Gly18 with the inserted 
6xHis-tag on the C-terminus). 
 
Primers were designed to introduce new DNA fragments into the AQP8-cmyc-His-
tag construct. The cloning strategy for AQP8-TEV-cmyc-His-tag and AQP8-His-tag 
constructs was based on the primers annealing, insertion of the modified DNA into the 
vector and an amplification of AQP8 gene with modified fragments in the pPICZΒ vector 
in E. coli. To the MG18-AQP8-His-tag construct a shorter N-terminus was introduced by 
PCR using designed primers and the construct AQP8-His-tag as the template. The PCR 
product was introduced to E. coli cells and amplified. Isolated plasmid DNA was 
linearized and transformed into the P. pastoris cells by electroporation and integrated into 
a yeast genome by homologous recombination.  
Since the recombinant P. pastoris had the Zeocin resistance gene, the yeast 
transformants were selected using Zeocin as a selection marker. The Zeocin, which is an 
antibiotic isolated from Streptomyces verticillus, enters the cell removing the copper from 
its structure, then binds to the DNA and cleaves it causing cell death [126]. The Zeocin 
resistant protein, a product of the Streptoalloteichus hindustanus bleomycin gene, binds 
stoichiometrically to antibiotic and inhibits the DNA cleavage. 
 In yeast the gene expression was under the control of the promoter (AQX1) of 
alcohol oxidase, which is a key enzyme in methanol metabolism. The protein production 
was induced by change from glycerol (BMGY) to methanol (BMMY) as the carbon source 
in the medium. Induction was continued for 6 days before cells were harvested and 
disrupted in the Bead Beater, crude membranes were isolated and stored at -80˚C. The 
selection of the best expressing P. pastoris clones was carried out on YPD agarose plates 
with increasing Zeocin concentrations. During the homologous recombination multiple 
insertions into yeast genom are possible, thus it is important to select the clone that is 
properly growing and expressing protein at the highest possible antibiotic concentration. 
For each construct a few colonies were picked up from the plates with the highest Zeocin 
concentration, grown one day in growth medium (BMGY) and 6 days in methanol medium 
(BMMY) with regular addition of 0.5% methanol. Then cells were harvested by 
centrifugation, disrupted, membranes collected and analyzed by a western blot. Then the 2 
clones of each construct with the most intensive signal were stored in glycerol stocks and 
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later used for the expression. 
 Purification of AQP8-TEV-cmyc-His-tag and AQP8-His-tag constructs 
Two new AQP8 constructs (AQP8-TEV-cmyc-His-tag and AQP8-His-tag) were 
overexpressed in P. pastoris and purified as described in 2.1.10. In the case of AQP8-His-
tag construct, after solubilization in DM, the Ni-NTA affinity chromatography was 
performed to obtain highly pure protein for 2D crystallization (Figure 2.15 c).  For AQP8-
TEV-cmyc-His-tag, beside the Ni-NTA agarose purification step, additional TEV protease 
digestion was performed. Whereas, for construct AQP8-His-tag elution resulted typically 
in 2 mg of pure protein per 1 l of P. pastoris culture, for construct with a TEV protease 
cleavage site the yield was 3-fold lower. No losses of protein were found during 
flowthrough or a column wash. In spite of minor impurities detected on the NuPAGE, the 
single particles EM analysis confirmed that specimens were homogenous, no aggregates 
occurred and a tetrameric state of protein was observed. Single particles of AQP8-His-tag 
were more homogenous than particles of AQP8-TEV-cmyc-His-tag. 
 
 
Figure 2.15: Purification of AQP8-TEV-cmyc-His-tag and AQP8-His-tag constructs. (a) 
NuPAGE. Monomers, dimers, trimers and tetramers of AQP8 are visible on the gel. (b) 
Single particles of AQP8-TEV-cmyc-His-tag construct. (c) Single particles of AQP8-His-
tag construct. Scale bars correspond to 100 nm. 
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 2D crystallization of AQP8-His-tag construct 
The protein concentration of eluted His-tagged AQP8 was typically 0.5 – 1.5 
mg/ml making it possible to set up 2D crystallization trials at the protein concentration of 
0.5 – 1 mg/ml. The conditions that were screened in dialysis buttons were shown in Table 
2.4. 
 
Table 2.4: Parameters tested during 2D crystallization of AQP8-His-tag construct 
 
PARAMETER RANGE TESTED 
Lipids E. coli polar, DMPC, DOPC, POPE:POPC (3:7), POPA:POPE:POPC (1:2:7) 
LPR 0.1 – 0.5 
Protein concentration 0.5 - 1 mg/ml 
pH 6.0 - 8.0 
Buffer MES, Hepes, Tris 
NaCl / KCl 100 mM – 200 mM 
MgCl2 0 - 20 mM 
EDTA 0 - 10 mM 
DTT 0 - 5 mM 
Glycerol 0 - 10% 
Temperature profile 20°C→37°C→20°C, 37°C→20°C 
 
In the initial attempt, the 2D crystallization conditions and temperature profile used 
for the previous construct were tested as described in 2.3.2. The suitable LPR was 0.3, the 
best crystals were formed at high protein concentrations and glycerol had a positive 
influence on the crystals formation. In the presence of E. coli polar lipids and chelating 
agent EDTA, at neutral pH, aquaporins formed vesicles that, however, did not exhibit any 
crystallinity (Figure 2.16 a). Addition of 5 mM MgCl2, instead of EDTA, resulted in 
formation of crystalline vesicles. Knowing that pI of new construct was shifted from 6.18 
to 7.14, the pH was slightly increased to 7.2 and when the reconstitution was done in a 
mixture of phosphatidyl lipids POPA:POPE:POPC at a ratio of 1:2:7, with 5mM MgCl2, 
AQP8 formed 2D crystalline sheets (Figure 2.16 b). The unit cell parameters of formed 
crystals were a = b = 65Å, γ = 90° (Figure 2.17). 
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Reconstitution in DMPC lipids, which have a phase transition temperature of 23˚C, 
was done directly in 37˚C and depending on pH resulted in formation of long tubular 
crystals of diameter of 1 µm (in pH 6.0, Figure 2.16 c) and 0.5 µm (in pH 6.5, Figure 2.16 
d). However, diffraction of these crystals was worse than sheets formed in phosphatidyl 
lipids. In the presence of 100 mM KCl instead of NaCl, narrow tubes were observed. 
 
 
Figure 2.16: 2D crystallization trials of AQP8-His-tag construct. (a) In the presence of E. 
coli polar lipids and chelating agent EDTA aquaporins formed vesicles. (b) In the presence 
of 5 mM MgCl2 and phosphatidyl lipids large crystalline sheets were observed. In DMPC 
lipids at pH 6.0 and 6.5 the long tubular crystals of diameter 1 µm (c) and 0.5 µm (d), 
respectively, were formed. Scale bars correspond to 500 nm in (a) and (d), 200 nm in (b), 2 
µm in (c). 
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Figure 2.17: Negatively stained AQP8-His-tag crystal imaged in CM-100 EM at 
magnification 13500x (a) and 50000x (b). (b) is highlighted with blue dashed line square in 
(a). (c) The Fourier-transformed image. Unit cell parameters are a = b = 65Å, g = 90°. (d) 
Filtered and backtransformed image of AQP8 tetramers. Scale bars correspond to 200 nm 
in (a), 100 nm in (b) and 10 nm in (d).  
2.3 Discussion 
2.3.1 Expression of AQP8 in yeast Pichia pastoris and protein purification 
Large amounts of the pure and functional protein are needed in order to obtain the 
high-resolution protein structure. It has been reported that membrane proteins have certain 
preferences for expression regarding the lipid content of the host [127], which makes the 
host selection critical. During heterologous expression, in parallel to the host strain, the 
limiting factors are temperature, culturing media and time of induction. Overexpression of 
several AQPs using Pichia pastoris system has been described in [124]. Accordingly, to 
obtain the high level of AQP8 expressed in yeast, only the induction time (144h) was 
optimized.  
Treating the membrane fraction with urea and alkali to strip off the peripheral 
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membrane proteins and thus improve purity of membrane fraction was reported for the 
native tissue [128] and heterologously expressed AQPs [21, 124]. However, due to the low 
yield of purified AQP8 after the urea and alkali treatment, we have purified the protein 
directly from the total membrane fraction. In parallel to activity essays a wide screen of 
solubilizing detergents was performed (M. Fellert et al., unpublished results). It was found 
that the low CMC detergent DDM as well as high CMC detergents DM, Cymal-6 and Fos-
choline-12 are equally efficient for solubilizing P. pastoris crude membranes. In order to 
use dialysis as 2D crystallization method and taking into account the high-solubilization 
yield, protein stability and the lowest contamination level, DM was selected. DDM, 
frequently used detergent with low CMC, which stabilizes the structure of membrane 
proteins in solution, was used in our 2DX crystallization robot along with methylated β-
cyclodextrin to complex the detergent. Extending the solubilization time to 3-4 hours at 
room temperature significantly increased the AQP8 solubilization yield. Furthermore, a 
rather high imidazole concentration during the affinity column washing step was necessary 
to eliminate all contaminants. In summary, a reproducible protocol to obtain well-purified 
samples of AQP8 adequate to perform 2D crystallization trials was established. 
Monodispersity and homogeneity of samples containing human AQP8 purified in 
DM and DDM was verified by single particle EM. In both detergents, the tetrameric 
organization of the protein is reflected in the square shape of the particles, specimens did 
not contain aggregates or contaminants indicating that AQP8 was homogenous and stable. 
2.3.2 Two-dimensional crystallization of AQP8 
 The vast majority of common crystallization conditions that led to successful 
crystallizations of aquaporins (Table 2.5) were tested for human AQP8. In particular, 
different pH values and additives were screened, and turned out to be crucial to find the 
proper crystallization buffer ingredients. When reconstituted in a mixture of neutral 
phosphatidyl lipids, with optional addition of negatively charged lipids, AQP8-cmyc-His-
tag formed ordered 2D crystals. The double-layered crystals appeared as large crystalline 
protein-lipid arrays about 2 µm wide and with the length of several micrometers. AQP8 
sheets were found in the presence of EDTA, at pH 7.0 and LPR 0.25-0.3.  
It was reported previously that the addition of Mg2+ to the crystallization buffer, 
either in the form of MgCl2 or as MgSO4, improves the quality of His-tagged protein 
crystals [129]. Magnesium cations are required for 2D crystallization of the vast majority 
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of aquaporins (Table 2.5) and other membrane proteins like bovine lens connexin, outer 
membrane porins and photosystem I reaction center [130-132]. Moreover, it was found 
that MgCl2 modulates electrostatic interactions by screening charges at the lipid bilayer 
surface [110] confirming the important role of divalent cations in 2D crystallization of 
membrane proteins. Here, in case of AQP8 with the long artificial His-tagged terminus, 
addition of Mg2+ to the crystallization buffer resulted in protein aggregation or formation 
of small vesicles, which often clustered together. In contrast, an addition of a versatile 
chelating agent (EDTA) resulted in large fractions of well-ordered sheets.  Presumably the 
elimination of divalent and trivalent cations from the crystallization buffer promoted 
electrostatic interaction of the phosphocholine (PC) and phosphoethanolamine (PE) polar 
groups [133], which appeared to facilitate AQP8 crystals formation.   
Screening for the best crystallization conditions led to the conclusion that the 
temperature profile had a significant influence on the formation, size, and quality of 
crystals. A change of temperature, after the appropriate time, from room temperature to 
37°C, resulted in formation of crystalline AQP8 arrays. Presumably long tubular crystals 
of diameter of 2 µm that formed initially at room temperature broke and became open due 
to the higher rigidity of lipids after the detergent removal. Sheet formation from open 
tubular crystals would then be subsequently facilitated by the higher flexibility of lipids 
after the shift to the higher temperature.  
In the 2DX robot, using the cyclodextrin-driven method for detergent removal, 
AQP8 was reconstituted as double-layered crystalline sheets or vesicles of a few 
micrometers in diameter that were densely packed with proteins. A fully automated 
crystallization robot used for screening of crystallization conditions, in parallel to the 
kinetics of the reconstitution processes, controlled the temperature profile and monitored 
the crystal formation by light scattering. The detergent removal rate has a significant 
influence on the quality and size of 2D crystals for any membrane protein [134-136]. It 
was observed that the use of lower cyclodextrin rate during reconstitution resulted in 
formation of large AQP8 sheets instead of proteoliposomes. The rate should be high to 
stabilize the protein in the lipid environment, but sufficiently low to allow proteins to pack 
regularly in the bilayer.  
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Table 2.5: Two-dimensional crystallization of aquaporins to date. 2D/3D map resolutions, 
2D crystallization conditions and crystal symmetries are listed. References: [26, 30, 33, 
129, 137-141]. 
 
Different 2D crystallization conditions resulted in tubular, vesicle or sheet-like 
crystals and hence diverse protein packing arrangements in reconstituted lipid bilayers. In 
the majority of cases, the power spectra showed two sets of diffraction spots indicating two 
crystalline layers and thus double-layered crystal or collapsed vesicles. The final 2D 
AQUAPORIN 
RESOLUTION 
[Å] 
CRYSTALLIZATION CONDITIONS 
[METHOD, DETERGENT, LIPIDS, LPR, BUFFER] 
CRYSTAL 
SYMMETRY 
AQP0 1.9 (3D) 
Dialysis buttons 
DM 
DMPC 
0.25 
10mM MES pH 6, 150 mM NaCl, 50 mM MgCl2, 5 mM DTT  
P4212 
AQP1 3.8 (3D) 
Dialysis machine 
OG 
E. coli lipids 
0.5 
20 mM Tris-HCl pH 6, 250 mM NaCl, 1 mM DTT, ± 10-100 mM Mg2+ or Ca2+  
P4212 
AQP2 
6 x His-tag 4.5 (3D) 
Dialysis machine 
OG 
E. coli or Heart polar lipids 
0.5 
20 mM MES pH 6, 100 mM NaCl, 5 mM MgCl2 or MgSO4, 5 mM Histidine  
P2212 
AQP4M23 
6 x His-tag 3.2 (3D) 
Dialysis buttons  
OG 
E. coli total lipid extract 
1.0 
10 mM MES pH 6, 100 mM NaCl, 50 mM MgCl2, 2 mM DTT, 10% glycerol 
P4212 
AQP9 7 (2D) 
Dialysis buttons 
OG 
DMPC 
0.4-0.6 
20 mM MES pH 6, 150 mM NaCl, 50 mM CaCl2,1 mM DTT 
P4212 
AQPZ 
10 x His-tag 8 (2D) 
Dialysis buttons and Eppendorf tube caps  
OG 
POPC:DMPC (1:1) 
0.3 - 2 
20 mM Citrate pH 6, 200 mM NaCl, 100 mM MgCl2, 10% glycerol 
P4212 
GlpF 
10 x His-tag 
3.7 (2D) 
6.9 (3D) 
Dialysis machine 
OG 
E. coli total lipid extract 
0.6 - 1.4 
10 mM Tricine pH 8, 100 mM NaCl, 5 mM MgCl2, 10 mM DTT  
P4 
SoPIP2;1 5 (3D) 
Dialysis machine  
OG 
E. coli polar lipid extract 
0.3-0.4 
20 mM Tris-HCl pH 8, 100 mM NaCl, 50 mM MgCl2, 2 mM DTT 
P4 
 rarely P2212 
AtTIP3;1 7.7 (2D) 
Eppendorf tube caps 
DHPC 
Soybean phosphatidylcholine  
25 mM TEA pH 7.5, 100 mM NaCl, 0.1 mM EDTA, 1 mM DTT, 0.1 mM 
Butylated hydroxytoluene (antioxidant) 
P2 
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projection map of AQP8-cmyc-His-tag at resolution of 8 Å revealed individual monomeric 
aquaporins in a tetrameric organization with a well visible central depression. AQP8 packs 
into arrays with p4 symmetry, analogously to GlpF [139] and SoPIP2;1 [140], housing one 
tetramer per unit cell of size 72 Å.  
Atomic force topographs recorded from AQP8 2D crystals adsorbed to the mica 
showed the crystal thickness to be 12 nm. Taking into account thickness of the single-
layered 2D crystals of the bacterial aquaporin AQPZ (5.7 nm) [142] and human AQP1 (5.8 
nm) [143, 144] the measured AQP8 crystals consisted of two layers. No single layers were 
detected during AFM measurements, however cluster areas having a thickness of about 24 
and 36 nm made of 2 and 3 double 2D crystal layers, respectively, were frequently 
observed. In parallel, 2D crystals were gold labeled using Ni-NTA-bound gold beads; the 
result indicated that C-terminal His-tags were exposed on the surface of the crystal.  
Taken together, the EM, AFM and gold labeling results suggest that AQP8 2D 
crystals expose the cytoplasmic side, N- and C- termini, of AQP8-cmyc-His-tag to the 
medium, while the extra-cellular side is trapped within the double-layered sandwich, a 
packing observed for AQP0 [26], AQP4 [33] and SoPIP2;1 [140].  
2.3.3 Analysis of digested AQP8 
With the purpose of improving the crystallization and the resolution of projection 
maps, the 2D crystals were exposed to protease Lys-C. In the 283-aa sequence of the 
human AQP8 gene, seven possible Lys-C cleavage positions were found. However, when 
the protein is embedded in a lipid bilayer only one Lys on the N terminus (K11) and 3 Lys 
on the C terminus (K248, K254 and K265) were predicted from the sequence alignment to 
AQP1 to be exposed to enzymatic treatment. The two Lys (K175, K177) located on the 8-
aa long cytosolic D-loop and one Lys located in transmembrane helix 3 (K124) were 
supposed to be inaccessible for the enzyme. The digestion by Lys-C, when added after 36 
h of crystallization, yielded rectangular crystals with sizes of several micrometers in 
diameter, and diffracting up to 3 Å. Mass spectroscopy and SDS-PAGE analysis revealed 
that AQP8, ordered in 2D arrays after Lys-C treatment, had lost 11 amino acids of the N-
terminal region. To investigate the digestion process at the C-terminal end Ni-NTA-gold 
labeling and western blot able to detect His-tags were performed. Taken together, the 
results demonstrated that after protease addition the well diffracting crystal is composed of 
several populations of protein. Protease removes not only N- and C-terminal moiety but as 
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well in certain percentage of AQP8 hydrolyzes the Lys peptide bond on the D-loop. 
Surprisingly, experiments indicated that protein digestion resulted in systematic crystal 
distortions. This is revealed by the resulting diffraction patterns, which exibit 
symmetrically distributed stripes. In AQP1 and AQP4 the subunits in the tetramer interact 
with each other through cytoplasmic loop-D connecting helices 4 and 5 [33], hence it is 
possible that disruption of AQP8 loop-D resulted in weakening of the tetramer interactions. 
Although the diffraction peaks were visible even above the resolution 3 Å the regular 
crystal distortions prevented the exploitation of the high-resolution information by 
standard crystallographic methods. 
In view of the fact that the crystallization conditions were optimized, the removal 
of the loose termini by proteolytic treatment seems to be crucial for obtaining large, well 
diffracting rectangular double-layered sheets of AQP8. Thus, proteolytic cleavage of the 
long C-terminus improved the crystallinity considerably, which might be considered for 
the 2D crystallization of other recombinant membrane proteins bearing large tags that 
facilitate their purification. 
2.3.4 The reason of crystallization failure and new constructs strategy 
Human AQP8 crystallization trials resulted in a large variety of the crystal 
formation of different sizes and diverse protein packing arrangements in reconstituted lipid 
bilayers. In optimized crystallization conditions the resolution of electron diffraction of 
AQP8 crystals improved from 8 to 3 Å after addition of Lys-C protease that removed N- 
and C-terminal moiety. Unfortunately, in parallel to inducing a better protein arrangement 
the protease had also hydrolyzed the peptide bond on the D-loop that led to cleavage into 
two pieces of a certain percentage of AQP8 and possibly to a weakening of 
crystallographic interactions between the layers. The systematic crystal distortion resulted 
in diffraction pattern disturbances. Because the crystallization problem was clearly bound 
with too long, random coil, C-termini of the protein that destabilized the crystal formation, 
and the addition of Lys-C had other inhibitory effects, the only possible way to obtain 
better crystals was producing shorter constructs of AQP8. 
Three new shorter AQP8 constructs designed with aim to solve the high-resolution 
channel structure were introduced into the P. pastoris genome and expressed. The strategy 
was to modify the original construct in order to produce a protein having properties as 
similar as possible to the native human AQP8 and at the same time to allow its successful 
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crystallization. The first two constructs (AQP8-TEV-cmyc-His-tag and AQP8-His-tag) 
have modified C-termini, shortened by the introduction of protease TEV cleavage site or 
the direct removal of the artificial link residues. Only these two constructs have been 
investigated to date. The expression level of the original construct and AQP8-His-tag were 
comparable and allowed highly concentrated protein to be purified and to perform 2D 
crystallization trials. The AQP8-TEV-cmyc-His-tag expression was much lower; moreover 
the longer purification protocol was associated with some loss of the protein.  
Analysis of AQP8-His-tag crystallization results highlighted the role of protein 
purification tags and that the construct length has an influence on crystal formation. During 
the first attempts, AQP8-His-tag formed vesicles and crystalline sheets with crystal 
parameters a = b = 65 Å, γ = 90°. Interestingly, in the AQP8-His-tag construct 
crystallization addition of 5 mM MgCl2 was crucial to obtain ordered 2D crystals, 
strikingly different to the results with the original construct. The anticipated correlation 
between AQP8-His-tag pI of the protein and the optimal crystallization pH is consistent 
with obtained results since the theoretical pI of AQP-His-tag is 7.14 and optimal 
crystallization pH was 7.2. The protein had reconstituted easily in several crystallization 
conditions and in different lipid environments. When after the first screenings in negative 
stain EM the observed crystals were inspected by cryo EM, this showed that these crystals 
are not perfect and, unfortunately, are diffracting below expectations. 
The structure of AQP4, which is the major water channel in the mammalian brain 
and, similar to AQP0 [145], plays a key role in membrane adhesion, has been determined 
by electron microscopy in 2006 [33]. Like the human AQP8 it has an unusually long N-
terminus in the comparison to other mammalian aquaporins. It was reported that AQP4 
exists in two alternative splicing isoforms: as a full-length protein starting with Met1 
(AQP4M1) and an alternative shorter starting with Met23 (AQP4M23). Surprisingly, the 
large and well-ordered 2D crystals were formed only by the shorter protein version while 
full-length AQP4 did not crystallize. It was found that the order of AQP4M23 crystals was 
destroyed after addition of a Met1-Ile22 peptide to the 2D crystal solution, which pointed 
to the highly conserved Arg9 being responsible for the destabilization of orthogonal arrays. 
Although human AQP8 does not have any additional Met in the N-terminal sequence 
suggesting an alternative-splicing version, the unusually long N-terminus and the residue 
Arg18, which might correspond to the Arg9 in AQP4, could have a serious influence on 
the 2D crystal formation. After an alignment of AQP8 to the AQP4 sequence it turned out 
that these water channels both have extraordinary long N-termini (Figure 2.18). The 
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residue AQP4Met23 was aligned with AQP0Met1, AQP1Ala2 and AQP8Gly23. The 
sequence similarity of the AQP4 and human AQP8 N-termini led to the design and 
production of the truncated AQP8 construct starting from AQP8Gly23 (called MG18-
AQP8-His-tag), which, in the near future, may form well diffracting 2D crystals being the 
major prerequisite for the AQP8 high-resolution structure determination. 
Recently, it was reported that when AQP8 was expressed in yeast, in addition to the 
28-kDa AQP8 band on the SDS-PAGE, a 26-kDa band was also identified suggesting that 
protein import into the yeast mitochondria may be accompanied by a proteolysis of AQP8 
N-terminus polypeptide [60]. This study is another argument that speaks for the 2D 
crystallization of the shorter version of AQP8. 
 
 
Figure 2.18: The sequence alignment of four human aquaporins (AQP4, AQP8, AQP0, 
AQP1). High homology regions as well as AQP4 secondary structure are highlighted. 
Alignment was generated using ClustalW2 [65] (default parameters, matrix Gonnet250, 
number of iterations 10) and graphically illustrated by ESPript 2.2 [66]. Met23 of AQP4 
was marked with black arrowhead. 
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2.4 Conclusion 
The main interest in structure determination of the human AQP8 is connected with 
its unique position within the aquaporin family. The human AQP8 cDNA has been cloned 
in 1998 [54] and since then the intensive studies concerning its intravesicular localization 
and activity have been preformed [60, 146]. Expressed in the inner mitochondrial 
membrane of several mammalian tissues, found in liver, gastrointestinal tract, testis, 
airways and kidney cells, the ammonia-permeable AQP8 could be essential for the 
organism metabolism. 
Here, the overexpression in yeast Pichia pastoris, purification and 2D 
crystallization of human AQP8 was presented. Protein purity and homogeneity in different 
detergents, made it possible to perform wide crystallization screenings. By using different 
crystallization conditions and methods, ordered crystalline sheets were obtained. AFM, 
EM and gold labeling experiments revealed the double-layered nature of 2D crystals, 
tetrameric organization and exposed outwards protein N- and C- termini of AQP8 within 
2D crystals. In parallel, an enzymatic removal of N- and C- terminal moiety was the 
significant approach to obtain the fine diffracting crystals. 
The presented results and new designed constructs, AQP8-His-tag and AQP8 
truncated version, MG18AQP8-His-tag, are a step towards the goal to solve the high-
resolution structure of human AQP8. 
  
  
 
3 Structure and symmetry determination of the YscC 
oligomer 
 
Abstract 
 
The translocation of proteins across the biological membrane is an essential part of 
cellular life. The type III secretion system is a major factor for the virulence or symbiosis 
of many Gram-negative bacteria that infect plants and animals. Bacterial effector proteins 
are delivered via T3SS injectisome from the pathogen cytoplasm into the eukaryotic host 
cells, in which they modulate the host innate immune response.   
The outer membrane-localized YscC oligomer belongs to the secretin family and is 
one of the main components of the injectisome. In this study, the YscC complex was 
expressed in the avirulent strain of Yesinia enterocolitica and purified in order to construct 
a 3D model from cryo Electron Microscopy single particle images.  
Various approaches like rotary metal shadowing of trypsin digested oligomers, 
mass spectrometry and Scanning Transmission Electron Microscopy were used for 
oligomer symmetry evaluation. In spite of considerable effort the symmetry could not be 
precisely assigned and the value was estimated to be either C12 or C13. The generated 3D 
structure of the YscC complex disclosed the N-terminal flexible domain, which forms the 
part of a large chamber between the bacterial outer and inner membranes, the conical shape 
periplasmic domain, and two differently sized ring-shaped domains linked by fine density 
connectors corresponding to the outer membrane spanning regions. The sample 
trypsinization revealed the protease-resistant core of the protein. 
 Comparison of the sequence and structure of YscC to other, close or more distant 
related secretins made it possible to define homology regions located both on the N- and 
C-termini of the protein. 
 
Structure and symmetry determination of the YscC oligomer 
 70 
3.1 Materials and Methods 
3.1.1 YscC expression in bacteria Yersinia enterocolitica and the YscC 
oligomer purification 
 The pYV-cured Yersinia enterocolitica strain carrying plasmids pMA6 and pRS6 
containing the yscC and yscW genes, respectively, was grown in 40 ml brain heart infusion 
(BHI) broth at 37°C overnight. To induce expression of yscC, Y. enterocolitica strain was 
inoculated at OD600 of 0.1 in 4 liters of BHI broth supplemented with 0.4% glycerol, 20 
mM MgCl2, and 20 mM sodium oxalate (BHI-OX). In addition, ampicillin (1 mg/ml), 
nalidixic acid (25 mg/ml), and tetracycline (10 mg/ml) were used. The culture was grown 
for 2 h at room temperature, arabinose (final concentration, 0.05%) was added, and the 
culture was grown for 2 h at 37°C.  
 The entire YscC purification was performed on ice. Bacterial cells were washed 
with 0.9% NaCl and resuspended in 100 ml lysis buffer (50 mM Tris-HCl pH 8.5, 1 mM 
EDTA). After sonication at 4°C, cells were pelleted at 4000 g for 10 min and envelopes 
were removed by centrifugation at 41000 g for 1 h. Y. enterocolitica membranes were 
solubilized with 6 ml of extraction buffer containing 2% DDM (Anatrace), 50 mM Tris-
HCl pH 7.8, 250 mM NaCl, 5 mM EDTA and protease inhibitor (complete protease 
inhibitor; Roche) for 1 hour at room temperature. Not solubilized debris were removed by 
centrifugation at 100000 g for 1 h. After the addition of sucrose to the final concentration 
of 15% (wt/wt), the extracted membrane proteins were layered on top of a 20 to 40% 
(wt/wt) sucrose gradient in the gradient buffer (0.04% DDM, 50 mM Tris-HCl pH 7.8, 250 
mM NaCl, 5 mM EDTA, protease inhibitor) and centrifuged at 38000 rpm in SW41 rotor 
(Beckman) for 30 h. Sucrose gradient fractions containing the YscC oligomer were 
combined, dialyzed against chromatography buffer (0.04% DDM, 10 mM Tris-HCl pH 
7.8, 100 mM NaCl, 0.1 mM EDTA) and loaded on a MonoQ 5/50 GL (GE Healthcare) ion 
exchange column. The salt gradient ranged from 100 mM to 1 M NaCl. The YscC 
oligomer was eluted at 450 to 500 mM NaCl. The pure YscC oligomer was separated from 
YscC oligomer dimers and other proteins by gel filtration on Superose 6 10/300 GL 
column (GE Healthcare). Fractions containing the YscC oligomer were controlled by semi-
native 3-8% Tris-Acetate NuPAGE and stored in 100 µl aliquots at -20°C for electron 
microscopy. 
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3.1.2 Protein reconstitution into the lipids 
 The purified YscC oligomer was mixed with DDM-solubilized E. coli polar, 
DMPC and phosphatidyl lipids to a final protein concentration of 0.5 mg/ml and a final 
DDM concentration of 1% in an end volume of 100 µl. The LPRs of 0.5, 1 and 2 were 
tested. 10 µg of Bio-Beads (Bio-Rad) were added to the ternary mixture that was 
vigorously mixed overnight at room temperature. Negatively stained samples were 
checked and images were taken with a Phillips CM-10 electron microscope operated at 80 
kV. 
3.1.3 Cryo Electron Microscopy 
 5 µl aliquot of the purified Ysc oligomer sample (0.05 mg/ml) was adsorbed to the 
thin carbon-coated copper grid, washed with 4 drops of nanopure water and then plunge-
frozen in liquid ethane [147] using the Vitrobot (Maastricht Instruments) [148]. The 
Vitrobot is the fully automated, PC-controlled, rapid cooling device for vitrification of 
aqueous samples. The grid preparation process takes place in a humidity, and temperature, 
controlled chamber. The following parameters were controlled: humidity (80%), blotting 
excess fluid time (3.5 sec) and blotting force (+1).  The frozen grids were transferred to a 
storage box immersed in liquid nitrogen and then to the Philips CM200 FEG electron 
microscope with Gatan cryoholder. The microscope was operated at an accelerating 
voltage of 200 kV. Single particle electron micrographs were recorded on Kodak SO163 
film at a magnification of 50000x, at low electron doses and with defocus ranged between 
2 µm and 5 µm. Negatives were scanned with a Heidelberg Primescan D7100 drum 
scanner in a resolution of 2 Å /pixel. 
 
 
Figure 3.1 The vitrification Robot [148]. 
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3.1.4 The YscC oligomer trypsin digestion 
 100 µg of the purified YscC oligomer (0.1 mg/ml) was incubated with 1 µg/ml of 
N-p-tosyl-L-phenylalanine chloromethyl ketone-treated trypsin (Sigma) for 2 h at room 
temperature to cleave YscC N-terminal domain. Pefabloc was then added to concentration 
of 0.1 mg/ml, and the sample was immediately injected onto a Superose 6 10/300 GL 
column. A control experiment was performed under the same conditions but the trypsin 
was omitted. In both cases fractions were collected, aliquots were treated with phenol to 
dissociate oligomers [149] and analyzed by 4-12% Bis-Tris NuPAGE. Briefly, 0.2 ml of 
the oligomer sample was treated with 0.5 ml of 88% phenol at 70°C for 10 min, then 
cooled and centrifuged at 5000 rpm for 10 min at 4°C, and an aqueous phase (without an 
interface) was removed. The interface and the phenol phase were mixed with nanopure 
water at 70°C, centrifuged at 5000 rpm for 10 min at 4°C and an aqueous phase was 
discarded. The phenol phase was treated twice with 0.7 ml acetone and once with 0.7 ml of 
diethyl ether, the sample was centrifuged and a supernatant discarded after each step. 
Pellets were dissolved in 100 µl of 1X SDS-PAGE sample buffer, boiled and frozen.  
3.1.5 Metal Shadowing 
 5µl of purified trypsinized sample (0.04 mg/ml) was adsorbed on the carbon-
covered copper grid, blotted twice with Whatman filter paper, washed with 5 drops of 
nanopure water to remove excess detergent and quickly plunged into liquid ethane cooled 
to -176°C [147]. A frozen grid was transferred to the Balzers BAF400 freezeetching unit 
and freeze-dried at -90°C for 5 h in a vacuum of ~1.3x10-5 Pa. 1-2 nm layer of 
platinum/carbon was evaporated onto the grid rotating at angle of 45° (Figure 5). 
Electron micrographs were recorded on the CCD camera at Philips CM-10 at a 
nominal magnification of 50000x (at high defocus) and 100000x (at low defocus) as 
described in 2.2.5. EMAN Boxer [150] was used to collect two sets of particles (1300 
particles with box size of 70x70 pixels taken at magnification 50000x; 1000 particles with 
box size of 140x140 pixels taken at magnification 100000x, respectively) which were 
normalized, aligned and processed in EMAN software package [151]. 
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Figure 3.2: The metal shadowing technique. The sample was adsorbed on the grid, frozen 
in the liquid ethane, transferred to a vacuum evaporator and dried under optimized 
conditions. When filament of platinum was heated electrically the metal evaporated and 
felt over the rotating grid in a very thin layer. In order to stabilize the replica, the sample 
was coated with a carbon film [152]. 
3.1.6 Scanning Transmission Electron Microscopy 
5 µl aliquots of YscC samples were adsorbed for 1 min to the glow-discharged thin 
carbon-coated STEM grids. The grids were blotted to remove excess of liquid and washed 
with 8 drops of a quartz double-distilled water to remove detergent frozen by plunging into 
liquid N2, and freeze-dried at -80°C and 5x10-8 Torr overnight in the STEM. Tobacco 
mosaic virus (TMV) particles adsorbed on the separate grid and washed with 10 mM 
ammonium acetate were used as the mass standard. The Vacuum Generators (East 
Grinstead) HB-5 STEM, connected to a modular computer system (Tietz Video and Image 
Processing Systems) were used [153]. For a mass determination, the series of 512x512 
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pixels dark-filed images were recorded at the accelerating voltage of 80 kV and a nominal 
magnification of 200000x. The recording dose was 500 electrons/nm2. The digital images 
were evaluated with the IMPSYS program package (Figure 3.3). Particles were selected by 
circles to calculate the total mass, and then the background was subtracted. The mass of 
measured TMV was used for scaling the results. The mass values were compared and 
displayed in histograms and fitted with Gauss curves. 
 
 
 
Figure 3.3: STEM calculations were performed in program IMPSYS. Particles were 
selected by circles to calculate the mass. Red circles correspond to the background 
selection, dark blue to side views and blue to top views of the YscC oligomer, green to a 
contaminant (possibly GroEL).	
  
3.1.7 Mass spectrometry of the intact and the trypsinized YscC oligomer 
 Intact and trypsinized YscC oligomers were dissociated after phenol treatment 
[149] as described in 3.2.4. Single bands on the 4-12% Bis-Tris NuPAGE corresponding to 
the wild and digested YscC monomers were stained with silver [154], cut out from a gel 
and send to the Mass Spectrometry Facility, Biozentrum, University of Basel [111]. 
Proteins isolated from the gel were digested with trypsin and resulting peptides were 
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separated by the capillary reverse phase chromatography coupled to the mass spectrometer. 
The masses of the peptides were measured and used for the oligomer fragments 
identification. 
3.1.8 Single particle processing using EMAN 
 Single particles were selected from EM negatives with the EMAN`s Boxer 
software and processed using the EMAN 1.9 suite (Figure 3.6, [150], [151]). 
Approximately, 8000 negatively stained particles and 37200 particles from cryo EM 
images were collected for the processing.   
 Processing of single particles from cryo EM data 
Cryo EM negatives scanned with the resolution of 2 Å/pixel were displayed in the 
interactive program Boxer. Every selected particle was saved in a separate subimage of the 
size 148x148 pixels. All particle images were saved in a *.img/*.hed files and normalized 
(edgenorm).  
If the reconstructed model is supposed to have a resolution higher than the “first 
zero” of the Contrast Transfer Function (CTF), a CTF correction, which includes the phase 
of the images and an amplitude correction, has to be applied. CTF correction (command 
ctfit) was applied by inspecting the Fourier transform of each cryo EM negative. The CTF 
parameters (Cs – spherical aberration correction fixed by microscope; defocus; B factor 
/envelope function width  – defines the attenuation of amplitudes; amount of amplitude 
contrast) were determined and the predicted CTF curve was fitted to the displayed profile 
(Figure 3.5). CTF correction was done for all particle images from one negative. 
For the centering and aligning the particles, a command cenalignint averaged all of 
the particles together, and then aligned each particle to this average by shifting it by 
defined number of pixels. Not centered particles were discarded. The process was iterated 
until the particles stop moving. The 2D refinement (refine2d), which classifies raw 
particles to produce a set of high-contrast class averages, gave the first good impression on 
the data quality. An initial model threed.0a.mrc was generated with applied cyclic 11-, 12- 
and 13-fold symmetries (C11, C12 and C13) (startAny, startcsym).  
To determine orientations of particles and match them to the projection, each 
particle was compared to a set of reference projections. Refine command created the loop 
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that generated reference projections from starting model (project3d), classified images by 
comparing them to the reference projections (classesbymra), averaged classes 
(classalignall) and calculated the reconstruction from class averages (make3d). In parallel 
to the refinements with 11, 12 or 13-fold symmetry supplied as an input parameter (refine) 
the single particle 3D reconstruction based on the multi-refinement protocol (multirefine) 
was performed [155]. In EMAN, the resolution evaluation was performed with the 
program eotest, which splits each of the classes into halves and makes class averaging and 
3D reconstruction of two independent sets. From the Fourier Shell Correlation (FSC) curve 
the 0.5 criterion was used to determine the generated model resolution. 
The generated models were visualized in program Chimera [156] for interactive 
visualization and analysis of molecular structures.  
 
 
Figure 3.4: The particles were windowed into 148x148 pixels boxes using EMAN's Boxer 
software [150].  
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Figure 3.5: Program ctfit was run to determine the CTF parameters and apply the phase 
correction. A plot window, an image window, and the control panel are displayed. 
 
Figure 3.6: The typical EMAN reconstruction strategy pipeline with the commands used 
during the single particle processing. The strategy includes the following steps: picking of 
the particles, the CTF correction of images, generating the 3D initial model, finding 
particle orientations and calculating the 3D reconstruction using refine command.  
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 Processing of negatively stained particles 
Negatively stained particles were picked from CCD images taken at CM-10 
electron microscope at nominal magnification of 50000x, and processed in the similar 
manner as cryo EM particles except that CTF correction was omitted. Cyclic 12-, 13- and 
14-fold symmetries (C12, C13 and C14) were imposed to the 3D initial models. For 
negatively stained particles not only monomeric but as well dimeric form of the YscC 
oligomer was generated. 
 
3.2  Results 
3.2.1 YscC expression in bacteria Yersinia enterocolitica and the YscC 
oligomer purification 
 
 The pYV-cured, avirulent, Yersinia enterocolitica strain carrying plasmids pMA6 
and pRS6 containing the yscC and yscW genes, respectively, was used to express the YscC 
oligomer. The YscW, a pilot protein introduced into the strain, was necessary to produce 
and localize the YscC oligomer in the membranes [96, 99]. After cells sonication and 
harvesting, the Y. enterocolitica membranes were solubilized with 2% DDM, non-ionic 
detergent which is one of the gentler detergents with the very low CMC of 0.0087%. YscC 
oligomer was purified using the sucrose gradient, during which outer and inner Y. 
enterocolitica membrane proteins were separated, followed by an ion exchange as 
described in [95] and size-exclusion chromatography (Figure 3.7). From the MonoQ ion 
exchange column protein was eluted in two peaks, the first corresponded to the monomeric 
form and the second to the oligomer. The Superose 6 gel filtration column step was 
significant to separate the highly pure oligomer from small contaminants <50 kDa, YscC 
monomeric form (~63 kDa) and dimers made of YscC oligomers (~1.5 MDa). To avoid 
aggregation of solubilized protein, 100 mM NaCl was added to the all purification buffers. 
No other proteins were detected in the specimen by semi-native silver stained 3-8% 
NuPAGE, single particle EM or STEM. The yield of purification was approximately 0.1 
mg protein per liter of the Y. enterocolitica culture. 
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Figure 3.7: Purification of the YscC oligomer. Secretin was purified from Y. enterocolitica 
membranes solubilized with 2 % DDM detergent. Outer and inner membrane proteins were 
separated using the 20-40% sucrose gradient. (a) Elution profile on MonoQ 5/50 GL ion 
exchange column. Green dashed line corresponds to the salt gradient profile. Protein was 
eluted at 450 to 500 mM NaCl. First elution peak corresponds to monomers (64.24 kDa) 
and second to the oligomer (~800 kDa) YscC. (b) The pure YscC oligomer was separated 
from YscC oligomer dimers and other proteins by gel filtration on Superose 6 10/300 GL 
column in 10 mM Tris-HCl pH 7.8, 100 mM NaCl, 0.1 mM EDTA and 0.04% DDM. The 
highest peak corresponds to oligomer. (c) A silver stained 3-8% NuPAGE with the 
oligomer marked by black arrow purified on Superose 6 column. 
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3.2.2 Reconstitution trials of the YscC oligomer into the lipid bilayer  
 To investigate if the purified YscC oligomer could be reconstituted into the lipids 
the protein was mixed with DDM-solubilized E. coli polar extract, DMPC or phosphatidyl 
lipids (POPA:POPE:POPC, in ratio 1:2:7) to a final protein concentration of 0.5 mg/ml. 
The detergent was selectively removed by adsorption onto Bio-Beads. The best results 
were obtained for E. coli polar lipids at LPR 0.5. It was observed that oligomer particles 
formed small patches made of 10-20 particles in between the lipids (Figure 3.8). 
Additionally, oligomers were attached to the lipid vesicles of diameter 100-200 nm. 
Embedded into the lipids with the C-terminal protease-resistant secretin homology regions 
and keeping the N-terminal flexible domains outwards, oligomers were attached to the 
surface of vesicles. For DMPC and phosphatidyl lipids aggregates made of several to tens 
of oligomers were found.  
 
Figure 3.8: Reconstitution trials of the oligomer into the lipids. The purified YscC 
oligomer was mixed with DDM-solubilized E. coli polar lipids extract. The detergent was 
removed from the ternary mixture by Bio-Beads. (a) Small patches formed by a few 
particles between the lipids. Top views of particles are well visible. (b) YscC oligomers 
attached to the surface of the lipid vesicle making it possible to observe oligomers side 
views. C-terminal part of the protein is embedded into E. coli polar lipids and N-terminal 
Structure and symmetry determination of the YscC oligomer 
 81 
flexible part jut out of the vesicle. In the right bottom corner oligomers formed aggregates 
made of a number of particles. (c) YscC particles integrated into the lipid vesicle. Scale 
bars correspond to 100 nm. 
 
3.2.3 Removal of the flexible domain of the YscC oligomer 
 
Figure 3.9: Specimens of intact and trypsinized YscC negatively stained oligomers 
adsorbed to STEM grids visualized by EM. Whereas in (a) the oligomer occurs in side- 
and top- views orientations, in (b), after removal of N-terminal flexible domain and C-
terminal moiety, only top views are present. 
 
The YscC oligomer trypsinization was aimed to reveal the protease-resistant C-
terminal core, which is a homology region in all secretins. A removal of flexible domain, 
which covers part of trypsin-resistant core, could facilitate the discovery of the oligomer 
symmetry. 
The purified trypsinized and intact YscC complexes (Figure 3.9) were subjected to 
the size exclusion chromatography. The elution profiles are compared on Figure 3.10 a. 
The intact oligomer eluted at 12 ml and the protease-digested complex at 13 ml. For both 
samples, the peak at 15.5 ml of elution corresponded to a few monomers of oligomer 
together. For intact oligomers the peak at 10 ml corresponded to oligomer dimer 
complexes as confirmed by negative stain EM. STEM analysis (Figure 3.10 c-d) showed 
that the intact oligomer solubilized in DDM has a mass of 941 kDa (± 74 kDa) and 
trypsinized of 576 kDa (± 65 kDa).  
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After the phenol treatment of trypsinized YscC oligomer a single band with an 
apparent molecular size of ~32 kDa was determined by 4-12% NuPAGE (Figure 3.10 b).  
 
 
Figure 3.10: Mass measurements of intact and proteolyzed YscC oligomers. Both intact 
and digested oligomers were purified on Superose 6 10/300 GL column. Graph (a) presents 
elution profiles of intact and trypsinized (in ratio 1:10 and 1:100) oligomers. Red and blue 
models of intact monomer and dimer, and trypsinized monomer of YscC oligomer 
correspond to the elution peaks below. In models the trapezoid shape corresponds to a 
protease-resistant core region, red squares to the C-terminal part, and blue hearts to the 
flexible domain located at the N-terminus of the oligomer. b) A silver stained NuPAGE of 
dissociated by phenol treatment intact (64.24 kDa, mature protein 581 aa) and trypsinized 
(~ 32 kDa) YscC oligomers. The gel bands were cut off and analyzed by mass 
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spectroscopy. No additional bands were detected. (c-d) STEM mass analysis. The 
histograms show the mass distributions for the intact and trypsinized YscC complexes. The 
Gaussian is at (c) 941 ± 74 kDa (number of measurements, n = 250) for the intact YscC 
oligomer and at (d) 576 ± 65 kDa (n = 818) after trypsin treatment. 
 
Mass spectroscopy measurements of trypsinized sample indicated that the N-
terminal digestion occurred after Arg246 of YscC and the short form of the protein began 
with sequence 247VEADPSLNAIIVR. The last identified C-terminal protein fragment was 
LFIIEPRIID EGIAHHLALG NGQDLR526 indicating that the proteolyzed protein finished 
at Arg526 (Figure 3.11).  
Analysis of mass spectroscopy results was based on an alignment to secretin PulD, 
for which trypsin cleavage sites were reported [97]. It was also taken on the account that 
the N-terminal trypsin cut could equally well happen at Arg240 or Agr233 and fragments 
were not identified by mass spectroscopy. Comparing masses of the YscC oligomer cut 
from N-terminal at 3 possible places it was found that ~32 kDa of the protein mass was 
retained and 32 kDa lost after the protease treatment (Table 3.1). According to the mass 
spectroscopy measurements trypsin removed regions from both the N- and C- termini of 
YscC, leaving the protease-resistant secretin homology core region (C domain) 
corresponding to residues 247-526. The mass of the trypsin-resistant core (30.6-32.1 kDa) 
indicates that 48-50% of the mass of the YscC oligomer is removed by proteolysis. 
A previous study of YscC oligomer suggested the oligomer symmetry of 13 or 14 
[95]. Moreover, here, following the suggestion from the metal shadowing data (chapter 
3.3.5) and cryo EM (chapter 3.3.6) the C12 symmetry was also considered. After 
trypsinization, the oligomer is 365 kDa smaller (941 ± 74 kDa YscC intact – 576 ± 65 kDa YscC 
trypsin = 365 ± 98 kDa), which indicates that the average stoichiometry is about 11-12. The 
detergent contribution was assumed to be the same for intact and trypsinized specimen 
since the protease-resistant core region includes the membrane integrated part of the 
protein where most of the DDM detergent is bound. Assuming a micelle mass of 47 kDa 
(Anatrace catalogue: DDM micelle = 40 – 47 kDa), measured STEM masses of intact (941 
kDa) and trypsinized (576 kDa) oligomer, actual monomer masses (intact 64.24 kDa, 
trypsinized ~32 kDa) and the stoichiometry of 12, the amount of detergent bound to the 
both, intact and trypsinized, oligomers was calculated to be ~4 DDM micelles per particle. 
All calculations are combined in Table 3.1. 
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A B C D E F 
RETAINED  
YSCCTRYPSIN 
FRAGMENT  
[KDA] 
LOST 
YSCC 
FRAGMENT 
[KDA] 
STOICHIOMETRY 
(941 ± 74 KDA INTACT  
– 576 ± 65 KDA 
TRYPSIN  = 365 ± 98 
KDA) 
(365 ± 98 KDA ÷ B) 
MASS OF 
YSCCTRYPSIN 
 C12 
(A X 12) 
DETERGENT 
CONTRIBUTION 
IN YSCCTRYPSIN  
(576 ± 65 KDA  
– D) 
DDM 
DETERGENT 
MICELLE IN 
YSCCTRYPSIN 
(E ÷ 47 KDA) 
247VEAD..DLR526 
30.6 
33.6 10.9 ± 2.9 403.2 172.8 ± 65 3.7 ± 1.4 
241ASAQ..DLR526 
31.2 
33.0 11.0 ± 3.0 396 180 ± 65 3.8 ± 1.4 
234IPQ..DLR526 
32.1 
32.1 11.4 ± 3.0 385.2 190.8 ± 65 4.0 ± 1.4 
 
Table 3.1: Analysis of the trypsinized YscC oligomer. According to the mass spectrometry 
results masses of retained (A) and lost fragments (B) of YscC complex, oligomer 
stoichiometry (C), mass of truncated oligomer (D), the DDM detergent contribution (E) 
and number of micelles around trypsinized oligomer (F) were calculated. 
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Figure 3.11: Amino acid sequence of the YscC protomer. Peptides identified with mass 
spectrometry are underlined for intact YscC and highlighted with yellow for trypsinized 
YscC protein. Amino acids Arg and Lys at which trypsin cleavage could occur are orange 
and red, respectively. The signal peptide 1-26 aa, predicted in SignalP 3.0 Server [157], is 
highlighted with gray color. 
 
3.2.4  Samples homogeneity 
 Purification of the YscC oligomer was based on the protocol described in [95] 
which included solubilization of membrane proteins, sucrose gradient and ion exchange 
chromatography steps. The protocol was modified by the introduction of DDM detergent 
instead of Elugent detergent and adding the size exclusion chromatography purification 
step, which allowed to remove impurities, i.e. unbounded YscC monomers, from the 
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specimen and get the clean background crucial for STEM and cryo EM experiments 
(Figure 3.12). Exchange of Elugent, a non-ionic detergent composed of a mixture of alkyl 
glucosides, to DDM detergent resulted in a higher yield, exclusion of aggregates, more 
homogenous specimen and the clearer background. 
 
 
Figure 3.12: Comparison of specimens at different purification steps. (a) Electron 
micrograph of the YscC oligomer sample after MonoQ 5/50 GL ion-exchange column. (b) 
Introduction of the size-exclusion Superose 6 10/300 GL column purification step allowed 
eliminating all small contaminants visible in the specimen (a). Scale bars correspond to 
100 nm. 
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Figure 3.13: Electron microscopic analysis of negatively stained specimens of (a) the 
purified oligomer YscC, (b) dimer made of YscC oligomers, (d) the trypsinized YscC 
complex. (c) shows the oligomer YscC embedded in vitreous ice, in cryo EM. In the 
upper-right corner of each image red models of particles in given samples are shown. The 
flexible domain could have been observed only in (c). A trapezoid shape corresponds to a 
protease-resistant core region, red squares to the C-terminal part, and blue hearts to the 
flexible domain located at the N-terminus of the oligomer. Scale bars correspond to 100 
nm.  
 
The purity, homogeneity and monodispersity of the samples were checked using 
TEM. On the carbon-coated grids the YscC oligomer was present in random orientations. 
Ladder-like structures (side views) and ring-like structures (top views) were observed. 
Examination of the negatively stained trypsinized sample revealed mainly ring-like views 
(trypsin-resistant cores) (Figure 3.13).  
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Monomeric forms of intact oligomer formed in the buffer solution the dimers due 
to the C-terminal interactions. It was found that the flexible domain at the N-terminus 
(represented as blue hearts in Figure 3.14 a) was highly negative charged (Figure 3.11) 
while in the trypsin-resistant core region and the C-terminus the negative charges are 
neutralized by positively charged residues in the protein structure.     
Interestingly, the physico-chemical properties of the complex were modified by 
proteolysis. After removal of the N- and C-terminal moiety in the YscC monomers, the C-
terminal acquires negative charge, then an electrostatic repulsion excludes C-terminal 
interaction and the dimers are formed using N-terminal part of the core region (Figure 3.14 
b).  
 
 
Figure 3.14: Uranyl acetate-stained images of dimers formed by the (a) intact and (b) 
trypsinized YscC oligomers. Negatively charged parts of the protein are represented in 
blue. (a) In the intact specimen negatively charged flexible domains of proteins, 
represented as hearts in the model, are located on the outside. (b) After removal of the 
flexible domain from N-terminus and C-terminal moiety, the oligomers interact by N-
terminal parts of trypsin-resistant cores and trypsinized C-termini protrude outwards.   
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3.2.5 Metal Shadowing – determination of the oligomer symmetry 
 
 
Figure 3.15: From the left: scheme model of a 12-, 13- and 14-mer. 
 
 A previous study of YscC oligomer suggested symmetry of C13 or C14 [95]. To 
verify the stoichiometry, the trypsinized YscC oligomer was freeze-etched, metal-
shadowed and analyzed in TEM. The oligomers appeared mainly as ring-like structures 
(Figure 3.16 a). While for the intact complex the individual YscC monomers were not 
visible due to the flexible N-termini that masked out the signal, for trypsinized specimen 
averages were generated with the indicated 12-fold or 13-fold symmetry. Two sets of 
particles were analyzed. 1300 particles recorded at low defocus (box size of 70x70 pixels) 
and 1000 particles recorded at high defocus (box size of 140x140 pixels) were collected, 
normalized, centered and classified (refine2d) in EMAN software package [150]. In order 
to eliminate the possibility of signal loss due to the metal grain size that was similar to the 
protomer size, the pictures were taken at 2 different focuses and later the results were 
compared. The classes with indicated symmetry were obtained for both sets of the 
particles. Clearer averages were produced for particles taken at higher magnification.  
Examination of the trypsinized YscC complex in TEM after metal shadowing has 
revealed the individual YscC subunits, but unfortunately not yet well enough to distinguish 
between a 12- and 13-mer, the results are summarized on Figure 3.16. 
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Figure 3.16: Metal shadowing. Single particles analysis of top views from metal-shadowed 
trypsin digested YscC oligomers. (a) The partial overview of collected in Boxer, the 
display program associated with the EMAN software package [150], metal-shadowed 
particle set. Classes generated in EMAN out of (b) 1300 particles with box size of 70x70 
pixels taken at magnification 50000x and (c) 1000 particles with box size of 140x140 
pixels taken at magnification 100000x indicate the symmetries C12 or C13. 
3.2.6 3D structure reconstruction with EMAN 
Single particles were selected from EM negatives with the EMAN`s Boxer 
software and processed using the EMAN 1.9 suite [150]. Approximately 8000 negatively 
stained particles and 37200 particles from cryo EM images were collected for the 
processing. 
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 TEM 
Uranyl-acetate stained particles, both the YscC oligomer monomers and dimers, 
were boxed and processed in EMAN. Program generated the top view and side view 
classes (Figure 3.17 a). It was not possible to define the symmetry from the class averages. 
Additionally, the flexible domain at the N-terminus was not visible for the YscC 
monomers. In the side view averages of the symmetrized dimer the blurred gray clouds at 
the ends of particle correspond to the densities of flexible domains (Figure 3.17 b). Thus, 2 
different symmetries were imposed to generate initial 3D models (Figure 3.18). 
 
 
 
Figure 3.17: (a) Single particle classes generated out of 8000 negatively stained YscC 
oligomers in EMAN [150]. The program recognized monomers and dimers made of YscC 
oligomer. (b) Images of the symmetrized dimer top view, the side view, and the side view 
aligned to the symmetric axis. Cyclic 12-fold symmetry was imposed. Images are 
displayed as negatives.  
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Figure 3.18:  For negatively stained particles not only monomer (a-b) but as well dimer (c-
d) models of the YscC oligomer were generated. The following symmetries were imposed 
to the 3D models: 12-fold (a, c), 13-fold (b, d). 3D maps were obtained on contouring at 
100% of the mass. Scale bars correspond to 100 Å. (a) and (c) were presented as cross-
sections.  
 Cryo EM 
The isolation of the outer membrane ring complex formed by YscC has been 
optimized for cryo EM.  
Intact YscC oligomer samples were adsorbed onto thin carbon films before freezing 
in liquid ethane using Vitrobot. Cryo EM of unstained, frozen-hydrated protein showed 
both top-views and side-views of the YscC oligomer (Figure 3.20). Side view of the 
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complex displayed a ladder-shaped structure with the height of approximately 15 nm and a 
radius diameter of 6 nm. Occasional side-views of dimeric complexes were also visible 
(Figure 3.13 c). Cryo EM negatives were digitized, and more than 37000 projections of 
intact YscC complexes were selected for elucidating their 3D structure. 
 
 
Figure 3.19: 676 class averages of YscC oligomer at different orientations were generated 
during 2D refinement in EMAN for 37000 single particles. 
 
First, the individual projections of the randomly oriented complexes were classified 
according to their similarity. Many of the resulting class averages revealed a flexible 
domain protruding from one side of the complex. Being flexible this region tends to 
average out during the subsequent processing. Characteristic top-view and side-view class 
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averages are shown in the Figure 3.19. Top view class averages with 2 different inner radii 
were observed. The class averages were used for generating the 3D initial model with 
imposed C12-C13 symmetries (Figure 3.21).  
 
 
Figure 3.20: Salmonella typhimurium 
(Giantmicrobes) as the schematic 
representation of the YscC oligomer 
frozen in the vitreous ice. (a) Oligomer 
consists of the 3 main parts: flexible 
domain at the N-terminus (bottom), 
trypsin-resistant core (partial putative 
membrane domain, middle) and C-
terminal part (top). Probable 
membrane-spanning region of the YscC 
initial model (Figure 3.21) is marked 
with red arrow. 
In cryo EM the molecules are 
lying in random orientations in a thin 
layer of vitreous ice. Column (b) 
corresponds to possible views from the 
side. Column (c) shows top views. 
Column (d) illustrates how flexible 
domain of the protein artificially raises 
the number of generated side view 
classes of the oligomer.  
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Figure 3.21: The 3D model of the YscC oligomer with applied C12 symmetry after first 
refinement was used for high-resolution refinement. The images show (a) the cross-
section, (b) side view and (c) top view models. 3D map was obtained on contouring at 
100% of the mass of a dodecamer. Scale bars correspond to 100 Å. 
 
According to the single particle 3D reconstruction based on the multi-refinement 
protocol the 13-fold symmetry was preferred. However, when running individual 
refinements with 12 or 13-fold symmetry, supplied as an input parameter, the resolution 
obtained in either scenario was the same. Thus, two refined YscC models with symmetries 
C12 or C13 were generated (Figure 3.22). In both cases, when contouring at 100% of the 
mass of the complex, the refined model reveals a slightly conical, cylindrical structure of 
periplasmic domain closed at the N-terminus and two differently sized ring-shaped 
domains linked by fine densities, which correspond to the membrane spanning regions. 
Both models have flexible domain at the N-terminal, which tend to average out during the 
model refinement but could be visualized when the contour level is set to 160 percent of 
the oligomer mass (Figure 3.22 f). Despite the presence of the flexible domain the 
generated pore structure is closed from periplasmic side, which suggests that for YscC 
open conformation other injectisome components are necessary.  
Although both structures were solved with the same resolution of 12 Å, greater 
number of structural details, i.e. more distinct flexible domain or hanging domains in the 
spanning membrane region, is visible for the YscC complex with the C13 symmetry. These 
features are blurred or missing in the C12 structure. Interestingly, the putative membrane 
spanning domains are arranged in clockwise order in the C13 and counter-clockwise in 
C12 structure (Figure 3.22 d). Additionally, in the 13-fold model are regular clearances, 
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which in the 12-fold model are jagged. The height of both models without flexible domain, 
which is 55 Å long, is equal to 110 Å. The inner and outer diameters are slightly different 
in C12 (inner: 60 Å, outer: 145 Å) than in C13 model (inner: 58 Å, outer: 150 Å).  
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Figure 3.22: 3D structure of the YscC complex with applied symmetries C12 (top, red) and 
C13 (bottom, blue) both at resolution of 12 Å. (a-e) 3D map obtained on contouring at 
100% of the mass of a C12/C13 complex (not considering the detergent). (a) Side-view. 
(b) Vertical slice through the centre of the complex. (c) Top-view. (d) Horizontal slice 
made at position 1 as indicated in (a) and looking down. (e) Horizontal slice made at 
position 2 as indicated in (a) and looking down. (f) Map obtained on contouring at 160% of 
the mass of the C12/C13 complex. Scale bars correspond to 10 nm. 
 
Figure 3.23: Wall-eye stereo view of the YscC oligomer with the C13 symmetry. 
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Figure 3.24: Fourier Shell Correlation (FSC) curve. The YscC structure resolution 
was assessed to be 12 Å with the FSC=0.5 criterion from two independent half data sets. 
3.3 Discussion 
3.3.1 YscC expression in bacteria Yersinia enterocolitica and the YscC 
oligomer purification 
 The injectisome is part of the Yersinia enterocolitica weaponry. The YscC oligomer, 
which belongs to the family of the secretins, is a major structural injectisome component 
and forms a stable ring-like multimeric complex in the bacterial outer membrane.  
 YscC and lipoprotein YscW, a pilot protein necessary to increase the expression 
yield and properly localize the YscC complex in the membrane [99], were expressed in the 
avirulent Y. enterocolitica strain. The homooligomeric YscC was purified without its 
chaperone YscW, in contrast to the secretin PulD that copurifies with the pilot protein PulS 
[158]. Thus, the YscW is not a stable constituent of the formed oligomer. The protein 
purification protocol established in previous study [95] was modified in two steps, which 
were fundamental to obtain pure specimens. First, the change of solubilizing non-ionic 
detergent from Elugent to DDM reduced the amount of aggregates and thus improved the 
amount and quality of single particles. Second, the size exclusion chromatography 
purification step, which allowed the pure oligomer to be separated from small 
contaminants, YscC monomeric form and dimers made of YscC oligomers, and yielded the 
clean background necessary for STEM and cryo EM experiments. The purity, homogeneity 
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and monodispersity of the samples were examined by TEM. As result of the required 
adsorption to carbon film, two predominant oligomer orientations were observed, mostly 
ring-like structures (top views) and ladder-like structures (side views), which revealed the 
N-terminal flexible domain of YscC. 
3.3.2 Searching for the missing symmetry using various approaches 
 The rotational symmetry is an essential parameter necessary to construct the correct 
3D model of the YscC oligomer from single particle projections. For the intact YscC 
particles we could not predict the symmetry from the obtained class averages, thus it had to 
be provided as a parameter from additional experiments. Therefore, we calculated the 
symmetry using numerous methods: mass spectroscopy of native and trypsinized samples, 
mass determination by STEM and rotary metal shadowing of freeze-dried trypsinized 
complexes.  
  The flexible domain located on the N-terminal part of secretin is visible on the cryo 
EM negatives, whereas for negatively stained specimens there is only a slight presence of 
the shadow-like domain manifested by darker pixels. The flexible domain in generated 
YscC class averages (Figure 3.19) tends to blur the top view projections of particles where 
each protomer should have a visible distinct position. Therefore, removal of the N-terminal 
flexible domain was performed to facilitate the visibility of the C-terminal protease-
resistant core of the protein in freeze-dried metal shadowed samples.  
The YscC complex trypsin cleavage sites, Arg246 and Arg526, were identified by 
the mass spectrometry. According to the multiple sequence alignment to 4 different 
secretins (Figure 3.28) it was found that these cleavage sites correspond to the N-terminal 
trypsin cleavage site of InvG, Lys268 [98], and Lys617, the C-terminal trypsin cleavage 
residue of PulD [97], respectively. The phylogenetic tree of five secretins presented on 
Figure 3.26 shows the evolutionary interrelations between these proteins. The primary 
sequence of YscC is closer related to the InvG and MxiD secretins than to the EscC and 
PulD, T2SS secretin, which is located on the separate branch of the phylogenetic tree and 
is the most distant from the Yersinia secretin sequence. The large evolutionary distance 
between YscC and PulD sequences explains different size of N-terminal flexible domains, 
which in case of PulD consists of multiple additional insertions, which changes the relative 
positions of the cleavage site.  
  The attempt to determine the symmetry using the rotary metal shadowing, as it was 
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performed for PulD [97] (Table 3.2), was based on the assumption that every YscC 
protomer could be precisely identified and the metal grain size would not collide with the 
subunit size. Metal shadowing has revealed the individual YscC subunits but regardless of 
the methods of calculation the symmetry was oscillating between C12 and C13.  
 STEM analysis gave a mass of 941 kDa for the pure DDM-solubilized native YscC 
complex, including DDM, thereby strongly suggesting the presence of 12 subunits for 
which the calculated mass is 959 kDa. However, taking into account more precise 
calculations including trypsinized sample (for which the bound detergent mass was 
assumed to be identical as for native protein) and errors, symmetry between C11 and C12 
(with the considerable calculation error) was the most likely. 
 A previous study of YscC oligomer suggested the oligomer symmetry of 13 or 14 
[95]. The Elugent-solubilized YscC mass determined by STEM was appreciably higher, 
985 kDa, which had to be reduced by mass of the detergent retained by a membrane 
protein. Elugent, the non-ionic detergent mixture, analogical to the DDM detergent forms 
50-kDa detergent micelles. It was concluded that if the 280-kDa photosystem II complex 
was solubilized with one DDM micelle [159], the YscC oligomer had to be associated with 
several micelles, but no exact numbers were obtained. With the new knowledge gained 
from our experiments on non-trypsinized and trypsinized samples, about the number of 
micelles bound to the YscC complex, the symmetry C12 could be considered also for 
previous results, presented in [95]. 
 The cryo EM data of the intact YscC oligomer were used to construct 3D model. 
According to the single particle 3D reconstruction based on the multi-refinement protocol 
(as implemented in EMAN), the 13-fold symmetry is preferred. However, when running 
refinements with 12 or 13-fold symmetry, supplied as an input parameter, the resolution 
obtained in either scenario was the same. A very flexible domain at the N-terminal makes 
it difficult to precisely resolve the oligomer symmetry. The “floppy” part effectively masks 
the evenly distributed protomers. Moreover, these floppy parts comprise a significant 
fraction of the mass (i.e. contrast) and tend to misalign projections. Therefore it would be 
useful to collect and process the cryo EM data of the trypsinized samples of the YscC, 
without the N-terminal domain. These experiments are currently carried on in our 
laboratory. 
 In spite of the secretins homology, the number of oligomer subunits varies within the 
secretin family. The presence of 14 subunits has been reported for phage pIV multimer 
[160] and a dodecameric structure has been proposed for the T2SS secretins PulD [97] and 
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GspD [165], T3SS secretin MxiD [83] and PilQ that is involved in the assembly of type IV 
pili [161] (Table 3.2). Additionally, in the recently published study [162], for InvG, it was 
necessary to use a ring with 14 subunits to fit it into the Salmonella cryo EM density map 
using homology modeling.  
 In the secretin family, changes in the stoichiometry might arise over the evolution to 
allow the transport of macromolecules of different diameter like folded extracellular 
proteins, pseudopilins or bacteriophages. Only small changes in protein packing in the 
oligomer might be necessary to perform a change from 12 to 14 (or to 13, and vice-versa) 
secretin subunits. A similar explanation was given to the TatA isolated from the E. coli, a 
component of twin-arginine protein transport system, which forms channel complexes of 
variable diameter translocating across the inner membrane specific folded proteins of 
different sizes [163]. The 3D architecture of the TatA complex obtained by single particle 
cryo EM and the random conical tilt reconstruction suggest 12–35 monomers per complex. 
However, the observed variation in protein diameter suggests that number of protomers 
changes to match the size of the channel to the size of the substrate being transported. 
 
BIOLOGICAL SYSTEM TECHNIQUE  
OUTER/INNER 
DIAMETER 
[Å] 
SUBUNIT 
DIAMETER 
[Å] 
MW 
[KDA] 
SYMMETRY 
Yersinia enterocolitica  
T3S system YscC Cryo EM 
145/60 
150/58 
30 
25  
771 
835 
C12 
C13 
Yersinia enterocolitica  
T3S system YscC 
Rotary metal 
shadowing - - 771/835 C12/C13 
Yersinia enterocolitica  
T3S system YscC STEM - - 707/771 C11/C12 
Yersinia enterocolitica  
T3S system YscC STEM 155/80 - 835 C13 
Shigella flexneri  
T3S system MxiD 
Negative 
stain TEM 137/81 25 756 C12 
Klebsiella oxytoca   
T2S system PulD  
Trypsin digested 
Rotary metal 
shadowing 130/86 25 452 C12 
Klebsiella oxytoca  
T2S system PulD-PulS  Cryo EM 137/80 20 825 C12 
Escherichia coli filamentus 
phage pIV multimer 
Negative 
stain TEM 135/87 - 624/1248 C14/D14 
Escherichia coli filamentus 
phage pIV multimer Cryo EM 137/65 - 624/1248 C14/D14 
Neisseria meningitidis  
type IV pilus secretin PilQ 
Negative 
stain TEM 165/65 - 960 C12 
Vibrio cholerae 
T2S system GspD Cryo EM 155/55 - 888 C12 
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Table 3.2: Comparison of the known secretin structures, their outer and inner rings 
diameter, molecular weights and determined symmetries. Subunit diameters were 
measured for S. flexneri and K. oxytoca. Data within orange borders corresponds to this 
study. References: [83, 95, 97, 160, 164, 165]. 
3.3.3 Structure reconstruction of the oligomer 
 The secretin is a key component of the T3SS machinery in a number of Gram-
negative pathogens. Therefore, it is fundamental to establish the secretin location in the 
membrane and provide information about its structure. 
 Previously, the secretins were observed in EM as components of inner membrane 
vesicles (K. oxytoca PulD secretin, T2SS [166]) and as low-diffracting 2D crystals 
reconstituted in the presence of lipids (N. meningitidis PilQ secretin [161]). Top views of 
the oligomers showed large ring structure with an internal cavity and the side views 
revealed formation of at least two stacked ring-like regions [167, 168]. The studies on pIV 
secretin, using the gold labeling technique, revealed the ring-like arrangement of protomers 
in the oligomer [160]. 
On the basis of the sequence comparison secretins contain different homologous 
structural domains, particularly marked within the core region but also in the N-terminal 
flexible part (Figure 3.28). The limited proteolysis and mutagenesis experiments have 
shown that C-terminal trypsin-resistant core of secretins participates in the pore formation 
and protein oligomerization, while the N-terminal flexible domain is possibly involved in 
specific interactions [169, 170]. The location of the N-domain at the one end of the secretin 
was proved by gold labeling experiments performed with pIV [160]. Moreover, it was 
reported that the non-conserved C-terminal of secretin functions as the binding site for so-
called pilot proteins [171].  
Although no full-length atomic resolution structure of any secretin is known, the 
general secretin model based on previous studies [95, 97, 98] and the sequence analysis 
(Figure 3.25) could be built. Assuming that most of the β-structures of the YscC are 
embedded into the membrane and the α-helices are stabilizing the structure above and 
below the membrane, the β-barrel structure of the oligomer could be predicted (Figure 
3.25). 
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Figure 3.25: Secondary structure prediction of the YscC oligomer generated in program 
Sable [172]. Red rectangles correspond to α-helices, green arrows to β-strands. 
 
 
 
Figure 3.26: Phylogenetic tree as graphical representation of the evolutionary relationship 
between taxonomic groups. The scale bar represents the evolutionary distance: 0.1 equals 
10 substitutions per 100 amino-acid residues. Multiple sequence alignment of secretins 
was performed in ClustalW2 (Figure 3.28); the guide tree was drawn with PHYLIP [173, 
174].  
 
The first step to reach the structural information about the YscC oligomer was its 
reconstitution into a lipid bilayer. Both, top and side views of Yersinia oligomer could be 
observed as protein has embedded its C-terminal into the lipids and N-terminal domain 
stuck out of the lipid bilayer. However, no higher ordered 2D crystals were obtained. 
Subsequent steps to solve the YscC oligomer structure were single particle 3D 
reconstructions from cryo EM data, based on individual and multi-reference refinements, 
performed with EMAN. 
The single-particle cryo EM model of YscC consists of the conserved C-terminal 
protease-resistant region and the N-terminal flexible domain not observed in the previously 
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generated PulD model [97], only barely visible in InvG complexes from S. typhimurium 
[98] and recently observed in GspD (T2SS) from Vibrio cholerae [165]. The refined model 
(Figure 3.22) reveals a slightly conical, cylindrical structure with two differently sized 
ring-shaped domains linked by fine densities. The latter correspond to the membrane 
spanning regions, which were suggested in the PulD model. Comparison of the YscC and 
PulD side views confirmed the structure similarities but also drew attention to the small 
differences (Figure 3.27). Additionally, taking into account the complex behavior on the 
carbon-coated grid, it was observed that the YscC particle is less rigid than the PulD 
oligomer. The PulD model in comparison to the YscC model has more extensive C-
terminal structure, while the inner pore diameter remains similar. Furthermore, the YscC 
middle domain is more conical. Distant relatives, YscC and PulD, share a number of 
structural features, which suggest YscC to have an even higher similarity to the InvG (S. 
typhimurium) or MxiD (S. flexneri) that are much more closely related (Figure 3.26).  
The generated YscC model, similarly to the PulD [97] and PilQ [160] complexes, is 
closed (Figure 3.27). However, the YscC oligomer has the gating unit at the N-domain, 
while in the PulD and PilQ models plug within the pore is located central in the trypsin-
resistant region. The closed aperture in PilQ appeared to be the site to which the type IV 
pilus binds [175]. It is assumed that the YscC complex undergoes a conformational change 
to form the closed state as a result of lack of the YscD and YscJ inner membrane 
complexes.  
The structural changes of YscC caused by proteolysis and observed in negatively 
stained particles allow the flexible domain to be identified, which faces the periplasm. 
Interestingly, physico-chemical properties of the complex were modified by proteolysis. 
While trypsinized YscC had capacity to form dimers with its N-terminal part of trypsin-
resistant core region, the intact YscC used its C-terminus to form dimers. This 
phenomenon may be connected with to the exposure of highly negative residues on the C-
terminus of the YscC oligomer after removal of the N- and C-terminal moiety.   
Results from previous experiments on isolated PulD and InvG secretins suggested 
that the N-terminal flexible region could not be entirely resolved by EM because the 
detergent disorders the N-terminal region during purification. In the case of YscC the 
flexible domain is well visible on the single 2D projections, but tends to average out during 
the subsequent processing and could be visualized in the YscC 3D model only when the 
contour level [176] is set at 160 percent of the oligomer mass. Moreover, the densities 
connecting N-domain with trypsin-resistant core are not visible on the whole length. 
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Figure 3.27: 1:1 scale comparison of 3D volumes of two secretins PulD (K. oxytoca) [97] 
and YscC (Y. enterocolitica) obtained with the single particle cryo EM technique. On the 
left was presented the intact (white mesh) and the digested (blue) PulD complex at 
resolution of 17 Å, on the right the 12 Å-resolution YscC complex with symmetry C13. 
The horizontal lines represent the outer limits of the lipopolysaccharide/phospholipid outer 
membrane (~4.5 nm wide). The scale bar corresponds to 50 Å. 
 
The high level of conservation between all secretins suggests that sequence-diverse 
but topologically similar protein folds provide the common structure that allows for 
assembly of inner membrane rings characteristic for T2SS and T3SS. In the study [98], 
using EM, molecular modeling, protease digestion and mutagenesis, ring models of 
flexible domain of EscC and inner membrane rings of PrgH and EscJ were generated and 
placed into the EM electron density map of the S. typhimurium needle resulting in the final 
ring models within the assembled T3SS. Taking into account the injectisome electron 
density presented on the Figure 3.29, the YscC structure could cover both the PulD 
electron density and the crystallized N-terminal domain of EscC, together with additional 
20 aa which are in possible contact with inner membrane ring, fitting well in the 3D model 
of the needle complex. 
The observed architecture of the injectisome basal body filled with ring structures 
and linker regions (both observed in the YscC oligomer) highlights the importance of all 
components for the function of the assembled complex. 
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Figure 3.28: Multiple sequence alignment of T3S system secretins EscC (EPEC), YscC 
(Yersinia enterocolitica), InvG (Salmonella typhimurium), MxiD (Shigella flexneri) and 
the T2S system secretin PulD (Klebsiella oxytoca) was performed using ClustalW2 [65] 
(default parameters, matrix Gonnet250, number of iterations 10) and graphically illustrated 
by ESPript 2.2 [66]. T3S system specific homology region (corresponding to YscC (24-
224)) and protease resistant secretin homology region (corresponding to YscC (245-511), 
EscC (240-508) [98], PulD (310-597)) were highlighted. Secondary structure of N-
terminal flexible domain of EscC (21-174) as described in [98], was presented above the 
alignment. Trypsin cleavage sites were marked with orange arrowheads for YscC (Val247 
and Arg526) and black arrowheads for InvG (Ile269) [98] and PulD (Gln262/Gln298 and 
Lys617) [97]. PulD trypsin-resistant domain consists of two fragments F1 (262-297) and 
F2 (298-617), whereas the very conserved domain is CD2 (348-595).  
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Figure 3.29: Injectisome-chimera based on [98]. Known structures of different host 
injectisome components were docked into the 3D EM density map of the S. typhimurium 
T3S system basal body [81]. (a) Gray boxed image of full length (gray mesh) and trypsin 
digested (blue mesh) cryo EM structure of K. oxytoca secretin PulD [97] was imposed on 
the basal body model. The C-terminal protease resistant secretin homology region was 
visualized; the N-terminal specific secretin region (marked with black arrow) was nano-
gold labeled in the pIV secretin studies [160]. The gray radial distributed densities around 
PulD ring correspond to the last 50 C-terminal residues of secretin and are not conserved 
among secretins. (b) Flexible domain of EPEC EscC (21-174) [98] secretin docked into the 
model. The generated cryo EM full length YscC secretin model is composed of (a) and (b) 
parts. (c) S. typhimurium PrgH (170-362) [98] corresponds to the YscD which can act as 
connector between outer and inner rings. (d) EPEC EscJ (21-190) [102] corresponds to the 
YscJ and forms the inner ring.	
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3.4 Conclusion 
Secretins are major components of the type III secretion systems [76]. These 
systems play the essential role in the interactions between Gram-negative bacteria and 
eukaryotic hosts. Purified and visualized by EM the T3SS secretins are stable ring-shaped 
complexes with an internal cavity.  
In this study, the YscC oligomer was expressed in Yersinia enterocolitica, purified 
using an improved protocol [95] to obtain highly pure specimens. The 12 Å-resolution 3D 
structure of the closed YscC complex was calculated from 30000 projections of vitrified 
YscC. Single particle 3D structure reconstruction revealed the N-terminal flexible domain 
of YscC, which forms the part of a large chamber between bacterial inner and outer 
membranes, into which macromolecules might be transported. The core structure consists 
of the periplasmic conical-shape domain and two differently sized ring-shaped domains 
linked by fine density connectors corresponding to the membrane spanning regions. The 
gap between these rings is most likely the location of the OM. 
We used various approaches to reveal the oligomer symmetry, however we did not 
accomplish a precise answer. Although the STEM measurements evidently indicated 4 
DDM detergent micelles to be presented around the single secretin particle, due to large 
statistical errors the symmetry could not be firmly predicted. Both the rotary metal 
shadowing of trypsinized sample and intact YscC 3D reconstruction in EMAN pointed to 
C12 or C13 symmetry. Taking into account the sequence analogy to other secretins the 
symmetry C12 could be assumed, although to have a total confidence it would be 
necessary to carry out 3D reconstructions of the trypsinized samples in which the trypsin-
resistant core is revealed, and not masked by flexible domain of the oligomer. 
Alternatively, native as well as trypsinized oligomers could be analyzed by mass 
spectrometry able to resolve complexes in the MDa region. 
 
 
 
 
 
 
 
 4 Appendix  
 
The 2DX robot: A membrane protein 2D crystallization Swiss 
Army knife 
 
 
The publication “The 2DX robot: A membrane protein 2D crystallization Swiss Army 
knife” is published in Journal of Structural Biology, Volume 169, Issue 3, March 2010, 
Pages 370-378. 
 
My contribution to this project consisted in production in Pichia pastoris and 
purification of DDM-solubilized human AQP8, 2D crystallization conditions optimization 
and protein crystallization in 2DX robot, monitoring the crystallization process as function 
as methyl-β-cyclodextrin rates during protein reconstitution into the 2D crystals, and the 
TEM images and electron diffraction data acquisition.  
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5 Abbreviations 
 
2D  
3D  
aa 
AFM  
AOX1  
AQP  
AQP8  
AqpZ  
BCIP 
BHI broth   
BHI-OX  
BMGY  
BMMY  
CCD  
CHIP  
CMC  
CTF 
DDM  
DM  
DMPC  
DOPC  
DOPE 
DOPG  
DOPS  
DTT  
EDTA  
EM 
EPEC  
Two Dimensional 
Three Dimensional 
Amino acid 
Atomic Force Microscope 
Alcohol Oxidase 1 
Aquaporin 
Aquaporin 8 
Aquaporin Z from Escherichia coli 
5-Bromo-4-chloro-3-indolyl phosphate 
Brain Heart Infusion broth 
Sodium oxalate BHI 
Buffered Glycerol-complex Medium 
Buffered Methanol-complex Medium 
Charge Coupled Device 
Channel-forming Integral Protein 
Critical Micelle Concentration 
Contrast Transfer Function 
n-Dodecyl-b-D-maltopyranoside 
n-Decyl-b-D-maltopyranoside 
1,2-Dimyristoyl-sn-Glycero-3-Phosphocholine 
1,2-Dioleoyl-sn-Glycero-3-Phosphocholine 
1,2-Dioleoyl-sn-Glycero-3-Phosphatidylethanolamine 
1-Palmitoyl-2-Oleoyl-sn-Glycero-3-[Phospho-rac-(1-glycerol)] 
1,2-Dioleoyl-sn-Glycero-3-[Phospho-L-Serine] 
Dithiothreitol 
Ethylenediaminetetraacetic acid 
Electron Microscopy 
Enteropathogenic Escherichia coli 
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FEG  
FFT  
GlpF  
Glu-C  
IPLT  
kDa  
LB  
LPR  
Lys-C 
MBCD  
MBP 
MES  
MIP 
MS  
MW  
NBT 
Ni-NTA  
NuPAGE  
NPA  
OD600  
OmpF  
PAGE  
PCR  
PIP  
PMSF  
POPC  
POPE  
POPG  
POPS  
PVDF 
SDS  
SNR  
SoPIP2;1  
Field Emission Gun 
Fast Fourier Transform 
Glycerol facilitator from Escherichia coli 
Endoprotease Glu-C, protease V8 from Staphylococcus aureus 
Image Processing Library and Toolkit 
kilo Dalton 
Luria Bertani 
Lipid-to-Protein Ratio 
Endoprotease Lys-C, protease from Lysobacter enzymogenes 
Methyl-β-cyclodextrin 
Maltose Binding Protein 
2-(N-morpholino)ethanesulfonic acid 
Major Intrinsic Protein 
Mass Spectrometry 
Molecular Weight 
Nitroblue tetrazolium chloride 
Ni2+-Nitrilotriacetic acid 
Neutral pH polyacrylamide gel electrophoresis 
Asparagine - Proline - Alanine 
Optical Density at 600 nm 
Outer Membrane Porin F 
Polyacrylamide gel electrophoresis 
Polymerase Chain Reaction 
Plasma Membrane Intrinsic Protein 
Phenylmethylsulfonylfluoride 
1-Palmitoyl-2-Oleoyl-sn-Glycero-3-Phosphocholine 
1-Palmitoyl-2-oleoyl-sn-Glycero-3-Phosphoethanolamine 
1-Palmitoyl-2-Oleoyl-sn-Glycero-3-[Phospho-rac-(1-glycerol)] 
1-Palmitoyl-2-Oleoyl-sn-Glycero-3-[Phospho-L-Serine] 
polyvinylidene fluoride 
Sodium-dodecyle sulfate 
Signal-to-Noise ratio 
Spinacia oleracea Plasma Membrane Intrinsic Protein 2;1 
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STEM  
T2SS 
T3SS 
TaTIP2;1 
TEM 
TEV  
TIP  
Tris  
Yop 
YPD  
YscC  
Scanning Transmission Electron Microscope 
Type II secretion system 
Type III secretion system 
Triticum aestivum Tonoplast Intrinsic Protein 2;1 
Transmission Electron Microscope 
Tobacco Etch Virus 
Tonoplast Intrinsic Protein 
Tis(hydoxymethyl)-aminoethane 
Yersinia outer protein 
Yeast Peptone Dextrose 
Yersinia secretion component C 
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